{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:44:10Z","timestamp":1791233050766,"version":"4.1.0"},"reference-count":480,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014215","name":"Huxiang Youth Talent Support Program","doi-asserted-by":"publisher","award":["2023RC3072"],"award-info":[{"award-number":["2023RC3072"]}],"id":[{"id":"10.13039\/501100014215","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014215","name":"Huxiang Youth Talent Support Program","doi-asserted-by":"publisher","award":["2024RC3043"],"award-info":[{"award-number":["2024RC3043"]}],"id":[{"id":"10.13039\/501100014215","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recent spatially resolved, multi-omic, and functional studies have advanced understanding of the intratumoral microbiota (ITM), shifting attention from microbial detection in tumors to how microbial localization and host-cell interactions influence cancer phenotypes and therapeutic outcomes. In this review, we first trace the historical development of the field and synthesize current evidence on routes of microbial colonization, pan-cancer heterogeneity, and the spatial organization of ITM. We then discuss how ITM directly affects genomic stability, signaling pathways, metabolism, and cellular plasticity of cancer cells, while indirectly shaping tumor evolution through its effects on immune and stromal components within the tumor microenvironment (TME). We further assess the role of ITM in anticancer therapy, explicitly distinguishing mechanisms supported by direct evidence in tumors from those inferred primarily from gut microbiota-driven systemic effects. In addition, we summarize emerging strategies to target or exploit ITM, including antibiotics, phage strategy, engineered strategy and related microbiota-modulating interventions. Finally, we highlight the major challenges that continue to constrain the field, particularly low microbial biomass, contamination, limited spatial resolution, and insufficient in vivo functional validation. Together, these considerations position ITM as a context-dependent component of tumor ecosystems with potential relevance to tumor progression, therapeutic stratification, and biomarker development, while defining priorities for more rigorous and clinically actionable research.<\/jats:p>","DOI":"10.1186\/s43556-026-00473-w","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:18:38Z","timestamp":1779441518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intratumoral microbiota in cancer: molecular mechanism and therapeutic strategies"],"prefix":"10.1186","volume":"7","author":[{"given":"Yao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Dian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4424-9727","authenticated-orcid":false,"given":"Guangtong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"1","key":"473_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1059.","journal-title":"Cancer Discov"},{"issue":"3","key":"473_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016.","journal-title":"Cancer Cell"},{"issue":"10","key":"473_CR3","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/cac2.12597","volume":"44","author":"H Zhang","year":"2024","unstructured":"Zhang H, Fu L, Leiliang X, Qu C, Wu W, Wen R, et al. Beyond the Gut: The intratumoral microbiome\u2019s influence on tumorigenesis and treatment response. Cancer Commun (Lond). 2024;44(10):1130\u201367. https:\/\/doi.org\/10.1002\/cac2.12597.","journal-title":"Cancer Commun (Lond)"},{"issue":"6494","key":"473_CR4","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368(6494):973\u201380. https:\/\/doi.org\/10.1126\/science.aay9189.","journal-title":"Science"},{"issue":"3","key":"473_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41588-019-0558-9","volume":"52","author":"M Zapatka","year":"2020","unstructured":"Zapatka M, Borozan I, Brewer DS, Iskar M, Grundhoff A, Alawi M, et al. The landscape of viral associations in human cancers. Nat Genet. 2020;52(3):320\u201330. https:\/\/doi.org\/10.1038\/s41588-019-0558-9.","journal-title":"Nat Genet"},{"issue":"20","key":"473_CR6","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1016\/j.cell.2022.09.005","volume":"185","author":"L Narunsky-Haziza","year":"2022","unstructured":"Narunsky-Haziza L, Sepich-Poore GD, Livyatan I, Asraf O, Martino C, Nejman D, et al. Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell. 2022;185(20):3789-806.e17. https:\/\/doi.org\/10.1016\/j.cell.2022.09.005.","journal-title":"Cell"},{"issue":"9","key":"473_CR7","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","volume":"186","author":"MJ Bender","year":"2023","unstructured":"Bender MJ, McPherson AC, Phelps CM, Pandey SP, Laughlin CR, Shapira JH, et al. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Cell. 2023;186(9):1846-62.e26. https:\/\/doi.org\/10.1016\/j.cell.2023.03.011.","journal-title":"Cell"},{"key":"473_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072217","author":"M Szczyrek","year":"2021","unstructured":"Szczyrek M, Bitkowska P, Chunowski P, Czuchryta P, Krawczyk P, Milanowski J. Diet, microbiome, and cancer immunotherapy-A comprehensive review. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13072217.","journal-title":"Nutrients"},{"issue":"6371","key":"473_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML, et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 2018;359(6371):104\u20138. https:\/\/doi.org\/10.1126\/science.aao3290.","journal-title":"Science"},{"key":"473_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14111083","author":"C Lombardo","year":"2024","unstructured":"Lombardo C, Fazio R, Sinagra M, Gattuso G, Longo F, Lombardo C, et al. Intratumoral microbiota: Insights from anatomical, molecular, and clinical perspectives. J Pers Med. 2024. https:\/\/doi.org\/10.3390\/jpm14111083.","journal-title":"J Pers Med"},{"issue":"1","key":"473_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1186\/s12967-024-05640-7","volume":"22","author":"Z Shi","year":"2024","unstructured":"Shi Z, Li Z, Zhang M. Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies. J Transl Med. 2024;22(1):837. https:\/\/doi.org\/10.1186\/s12967-024-05640-7.","journal-title":"J Transl Med"},{"issue":"1","key":"473_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41522-023-00446-9","volume":"9","author":"L Schorr","year":"2023","unstructured":"Schorr L, Mathies M, Elinav E, Puschhof J. Intracellular bacteria in cancer-prospects and debates. NPJ Biofilms Microbiomes. 2023;9(1):76. https:\/\/doi.org\/10.1038\/s41522-023-00446-9.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"5","key":"473_CR13","first-page":"547","volume":"2","author":"RH Major","year":"1930","unstructured":"Major RH. The Papyrus Ebers. Ann Med Hist. 1930;2(5):547\u201355.","journal-title":"Ann Med Hist"},{"issue":"8","key":"473_CR14","first-page":"824","volume":"111","author":"R Jackson","year":"1974","unstructured":"Jackson R. Saint Peregrine, O.S.M.--the patron saint of cancer patients. Can Med Assoc J. 1974;111(8):824\u20137.","journal-title":"Can Med Assoc J"},{"issue":"1","key":"473_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1017\/s002217240003309x","volume":"7","author":"LS Dudgeon","year":"1907","unstructured":"Dudgeon LS, Dunkley EV. The Micrococcus neoformans: Its Cultural Characters and Pathogenicity and the Results of the Estimation of the Opsonic and Agglutinative Properties of the Serum of Patients Suffering from Malignant Disease on this Organism and on the Staphylococcus Albus. J Hyg (Lond). 1907;7(1):13\u201321. https:\/\/doi.org\/10.1017\/s002217240003309x.","journal-title":"J Hyg (Lond)"},{"issue":"4","key":"473_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1084\/jem.13.4.397","volume":"13","author":"P Rous","year":"1911","unstructured":"Rous P. A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS. J Exp Med. 1911;13(4):397\u2013411. https:\/\/doi.org\/10.1084\/jem.13.4.397.","journal-title":"J Exp Med"},{"issue":"8","key":"473_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41571-024-00908-9","volume":"21","author":"SY Kwon","year":"2024","unstructured":"Kwon SY, Thi-Thu Ngo H, Son J, Hong Y, Min JJ. Exploiting bacteria for cancer immunotherapy. Nat Rev Clin Oncol. 2024;21(8):569\u201389. https:\/\/doi.org\/10.1038\/s41571-024-00908-9.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"473_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/prd.12566","volume":"96","author":"A Contreras","year":"2024","unstructured":"Contreras A, S\u00e1nchez SA, Rodr\u00edguez-Medina C, Botero JE. The role and impact of viruses on cancer development. Periodontol 2000. 2024;96(1):170\u201384. https:\/\/doi.org\/10.1111\/prd.12566.","journal-title":"Periodontol 2000"},{"key":"473_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-57362-1_1","volume":"217","author":"JT Schiller","year":"2021","unstructured":"Schiller JT, Lowy DR. An Introduction to Virus Infections and Human Cancer. Recent Results Cancer Res. 2021;217:1\u201311. https:\/\/doi.org\/10.1007\/978-3-030-57362-1_1.","journal-title":"Recent Results Cancer Res"},{"issue":"8336","key":"473_CR20","first-page":"1273","volume":"1","author":"JR Warren","year":"1983","unstructured":"Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1(8336):1273\u20135.","journal-title":"Lancet"},{"issue":"8390","key":"473_CR21","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/s0140-6736(84)91816-6","volume":"1","author":"BJ Marshall","year":"1984","unstructured":"Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1(8390):1311\u20135. https:\/\/doi.org\/10.1016\/s0140-6736(84)91816-6.","journal-title":"Lancet"},{"issue":"Pt 3","key":"473_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcancer.2022.05.001","volume":"86","author":"E Bess\u00e8de","year":"2022","unstructured":"Bess\u00e8de E, M\u00e9graud F. Microbiota and gastric cancer. Semin Cancer Biol. 2022;86(Pt 3):11\u20137. https:\/\/doi.org\/10.1016\/j.semcancer.2022.05.001.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"473_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189355","volume":"1880","author":"F Gui","year":"2025","unstructured":"Gui F, Zhang L, Xiao J, Zeng C. Decoding the role of intratumoral microbiota in gastric cancer. Biochim Biophys Acta Rev Cancer. 2025;1880(3):189355. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189355.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"20","key":"473_CR24","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1016\/j.cell.2022.09.015","volume":"185","author":"AB Dohlman","year":"2022","unstructured":"Dohlman AB, Klug J, Mesko M, Gao IH, Lipkin SM, Shen X, et al. A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. Cell. 2022;185(20):3807-22.e12. https:\/\/doi.org\/10.1016\/j.cell.2022.09.015.","journal-title":"Cell"},{"issue":"8","key":"473_CR25","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","volume":"185","author":"A Fu","year":"2022","unstructured":"Fu A, Yao B, Dong T, Chen Y, Yao J, Liu Y, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185(8):1356-72.e26. https:\/\/doi.org\/10.1016\/j.cell.2022.02.027.","journal-title":"Cell"},{"issue":"9","key":"473_CR26","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","volume":"187","author":"TW Battaglia","year":"2024","unstructured":"Battaglia TW, Mimpen IL, Traets JJH, van Hoeck A, Zeverijn LJ, Geurts BS, et al. A pan-cancer analysis of the microbiome in metastatic cancer. Cell. 2024;187(9):2324-35.e19. https:\/\/doi.org\/10.1016\/j.cell.2024.03.021.","journal-title":"Cell"},{"issue":"10","key":"473_CR27","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41590-020-0761-y","volume":"21","author":"J Leinwand","year":"2020","unstructured":"Leinwand J, Miller G. Regulation and modulation of antitumor immunity in pancreatic cancer. Nat Immunol. 2020;21(10):1152\u20139. https:\/\/doi.org\/10.1038\/s41590-020-0761-y.","journal-title":"Nat Immunol"},{"issue":"4","key":"473_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.Cd-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8(4):403\u201316. https:\/\/doi.org\/10.1158\/2159-8290.Cd-17-1134.","journal-title":"Cancer Discov"},{"issue":"1","key":"473_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-7-19","volume":"7","author":"H El-Mosalamy","year":"2012","unstructured":"El-Mosalamy H, Salman TM, Ashmawey AM, Osama N. Role of chronic E. coli infection in the process of bladder cancer- an experimental study. Infect Agent Cancer. 2012;7(1):19. https:\/\/doi.org\/10.1186\/1750-9378-7-19.","journal-title":"Infect Agent Cancer"},{"issue":"5","key":"473_CR30","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ccell.2021.03.004","volume":"39","author":"A Bertocchi","year":"2021","unstructured":"Bertocchi A, Carloni S, Ravenda PS, Bertalot G, Spadoni I, Lo Cascio A, et al. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver. Cancer Cell. 2021;39(5):708-24.e11. https:\/\/doi.org\/10.1016\/j.ccell.2021.03.004.","journal-title":"Cancer Cell"},{"issue":"4","key":"473_CR31","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","volume":"45","author":"R Daill\u00e8re","year":"2016","unstructured":"Daill\u00e8re R, V\u00e9tizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, et al. Enterococcus hirae and Barnesiella intestinihominis facilitate Cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity. 2016;45(4):931\u201343. https:\/\/doi.org\/10.1016\/j.immuni.2016.09.009.","journal-title":"Immunity"},{"issue":"81","key":"473_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abo2003","volume":"8","author":"Y Choi","year":"2023","unstructured":"Choi Y, Lichterman JN, Coughlin LA, Poulides N, Li W, Del Valle P, et al. Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity. Sci Immunol. 2023;8(81):eabo2003. https:\/\/doi.org\/10.1126\/sciimmunol.abo2003.","journal-title":"Sci Immunol"},{"issue":"2","key":"473_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.chom.2016.07.006","volume":"20","author":"J Abed","year":"2016","unstructured":"Abed J, Emg\u00e5rd JE, Zamir G, Faroja M, Almogy G, Grenov A, et al. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe. 2016;20(2):215\u201325. https:\/\/doi.org\/10.1016\/j.chom.2016.07.006.","journal-title":"Cell Host Microbe"},{"issue":"6369","key":"473_CR34","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1126\/science.aal5240","volume":"358","author":"S Bullman","year":"2017","unstructured":"Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science. 2017;358(6369):1443\u20138. https:\/\/doi.org\/10.1126\/science.aal5240.","journal-title":"Science"},{"issue":"9","key":"473_CR35","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1001\/jamaoncol.2022.2810","volume":"8","author":"H Qiao","year":"2022","unstructured":"Qiao H, Tan XR, Li H, Li JY, Chen XZ, Li YQ, et al. Association of intratumoral microbiota with prognosis in patients with nasopharyngeal carcinoma from 2 hospitals in China. JAMA Oncol. 2022;8(9):1301\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2022.2810.","journal-title":"JAMA Oncol"},{"issue":"1","key":"473_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcac006","volume":"4","author":"S Desai","year":"2022","unstructured":"Desai S, Dharavath B, Manavalan S, Rane A, Redhu AK, Sunder R, et al. Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cancer. NAR Cancer. 2022;4(1):zcac006. https:\/\/doi.org\/10.1093\/narcan\/zcac006.","journal-title":"NAR Cancer"},{"key":"473_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004698","author":"A Wong-Rolle","year":"2022","unstructured":"Wong-Rolle A, Dong Q, Zhu Y, Divakar P, Hor JL, Kedei N, et al. Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2022-004698.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"473_CR38","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1101\/gr.133926.111","volume":"22","author":"Z Jiang","year":"2012","unstructured":"Jiang Z, Jhunjhunwala S, Liu J, Haverty PM, Kennemer MI, Guan Y, et al. The effects of Hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res. 2012;22(4):593\u2013601. https:\/\/doi.org\/10.1101\/gr.133926.111.","journal-title":"Genome Res"},{"issue":"11","key":"473_CR39","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41579-018-0064-6","volume":"16","author":"NA Krump","year":"2018","unstructured":"Krump NA, You J. Molecular mechanisms of viral oncogenesis in humans. Nat Rev Microbiol. 2018;16(11):684\u201398. https:\/\/doi.org\/10.1038\/s41579-018-0064-6.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"473_CR40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ccell.2024.02.009","volume":"42","author":"A Rosendahl Huber","year":"2024","unstructured":"Rosendahl Huber A, Pleguezuelos-Manzano C, Puschhof J, Ubels J, Boot C, Saftien A, et al. Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer. Cancer Cell. 2024;42(3):487-96.e6. https:\/\/doi.org\/10.1016\/j.ccell.2024.02.009.","journal-title":"Cancer Cell"},{"issue":"1","key":"473_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46790-9","volume":"9","author":"R Tagaino","year":"2019","unstructured":"Tagaino R, Washio J, Abiko Y, Tanda N, Sasaki K, Takahashi N. Metabolic property of acetaldehyde production from ethanol and glucose by oral Streptococcus and Neisseria. Sci Rep. 2019;9(1):10446. https:\/\/doi.org\/10.1038\/s41598-019-46790-9.","journal-title":"Sci Rep"},{"key":"473_CR42","doi-asserted-by":"publisher","DOI":"10.1177\/1533033819867354","volume":"18","author":"I Chattopadhyay","year":"2019","unstructured":"Chattopadhyay I, Verma M, Panda M. Role of oral microbiome signatures in diagnosis and prognosis of oral cancer. Technol Cancer Res Treat. 2019;18:1533033819867354. https:\/\/doi.org\/10.1177\/1533033819867354.","journal-title":"Technol Cancer Res Treat"},{"issue":"8038","key":"473_CR43","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41586-024-08135-z","volume":"635","author":"M Jans","year":"2024","unstructured":"Jans M, Kolata M, Blancke G, D\u2019Hondt A, Gr\u00e4f C, Ciers M, et al. Colibactin-driven colon cancer requires adhesin-mediated epithelial binding. Nature. 2024;635(8038):472\u201380. https:\/\/doi.org\/10.1038\/s41586-024-08135-z.","journal-title":"Nature"},{"key":"473_CR44","doi-asserted-by":"publisher","unstructured":"Tozzi M, Fiore A, Travaglione S, Marcon F, Rainaldi G, Germinario EAP, et al. E. Coli cytotoxic necrotizing factor-1 promotes colorectal carcinogenesis by causing oxidative stress, DNA damage and intestinal permeability alteration. J Exp Clin Cancer Res. 2025;44(1):29. https:\/\/doi.org\/10.1186\/s13046-024-03271-w","DOI":"10.1186\/s13046-024-03271-w"},{"issue":"1","key":"473_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1158\/2159-8290.Cd-21-0912","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu Y, Fu K, Wier EM, Lei Y, Hodgson A, Xu D, et al. Bacterial Genotoxin Accelerates Transient Infection-Driven Murine Colon Tumorigenesis. Cancer Discov. 2022;12(1):236\u201349. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0912.","journal-title":"Cancer Discov"},{"issue":"37","key":"473_CR46","doi-asserted-by":"publisher","first-page":"15354","DOI":"10.1073\/pnas.1010203108","volume":"108","author":"AC Goodwin","year":"2011","unstructured":"Goodwin AC, Destefano Shields CE, Wu S, Huso DL, Wu X, Murray-Stewart TR, et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci U S A. 2011;108(37):15354\u20139. https:\/\/doi.org\/10.1073\/pnas.1010203108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"473_CR47","doi-asserted-by":"publisher","unstructured":"Koi M, Okita Y, Carethers JM. Fusobacterium nucleatum Infection in Colorectal Cancer: Linking Inflammation, DNA Mismatch Repair and Genetic and Epigenetic Alterations. J Anus Rectum Colon. 2018;2(2):37\u201346. https:\/\/doi.org\/10.23922\/jarc.2017-055","DOI":"10.23922\/jarc.2017-055"},{"key":"473_CR48","doi-asserted-by":"publisher","unstructured":"Pickova D, Ostry V, Toman J, Malir F. Aflatoxins: History, Significant Milestones, Recent Data on Their Toxicity and Ways to Mitigation. Toxins (Basel). 2021;13(6). https:\/\/doi.org\/10.3390\/toxins13060399","DOI":"10.3390\/toxins13060399"},{"key":"473_CR49","doi-asserted-by":"publisher","unstructured":"Huang B, Chen Q, Wang L, Gao X, Zhu W, Mu P, et al. Aflatoxin B1 Induces Neurotoxicity through Reactive Oxygen Species Generation, DNA Damage, Apoptosis, and S-Phase Cell Cycle Arrest. Int J Mol Sci. 2020;21(18). https:\/\/doi.org\/10.3390\/ijms21186517","DOI":"10.3390\/ijms21186517"},{"key":"473_CR50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.dnarep.2019.03.004","volume":"77","author":"AK McCullough","year":"2019","unstructured":"McCullough AK, Lloyd RS. Mechanisms underlying aflatoxin-associated mutagenesis - implications in carcinogenesis. DNA Repair (Amst). 2019;77:76\u201386. https:\/\/doi.org\/10.1016\/j.dnarep.2019.03.004.","journal-title":"DNA Repair (Amst)"},{"key":"473_CR51","doi-asserted-by":"publisher","unstructured":"Giam CZ, Semmes OJ. HTLV-1 Infection and Adult T-Cell Leukemia\/Lymphoma-A Tale of Two Proteins: Tax and HBZ. Viruses. 2016;8(6). https:\/\/doi.org\/10.3390\/v8060161","DOI":"10.3390\/v8060161"},{"key":"473_CR52","doi-asserted-by":"publisher","unstructured":"Maddocks OD, Scanlon KM, Donnenberg MS. An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins. mBio. 2013;4(3):e00152\u201313. https:\/\/doi.org\/10.1128\/mBio.00152-13","DOI":"10.1128\/mBio.00152-13"},{"issue":"1","key":"473_CR53","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2018.1563410","volume":"11","author":"I Olsen","year":"2019","unstructured":"Olsen I, Yilmaz \u00d6. Possible role of Porphyromonas gingivalis in orodigestive cancers. J Oral Microbiol. 2019;11(1):1563410. https:\/\/doi.org\/10.1080\/20002297.2018.1563410.","journal-title":"J Oral Microbiol"},{"issue":"14","key":"473_CR54","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1158\/1078-0432.Ccr-10-3363","volume":"17","author":"H Sihto","year":"2011","unstructured":"Sihto H, Kukko H, Koljonen V, Sankila R, B\u00f6hling T, Joensuu H. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin Cancer Res. 2011;17(14):4806\u201313. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-10-3363.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"473_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.04.040","volume":"11","author":"D Wang","year":"2024","unstructured":"Wang D, Zhang Y, Li Q, Li Y, Li W, Zhang A, et al. Epigenetics: Mechanisms, potential roles, and therapeutic strategies in cancer progression. Genes Dis. 2024;11(5):101020. https:\/\/doi.org\/10.1016\/j.gendis.2023.04.040.","journal-title":"Genes Dis"},{"issue":"4","key":"473_CR56","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1158\/0008-5472.Can-09-2755","volume":"70","author":"T Niwa","year":"2010","unstructured":"Niwa T, Tsukamoto T, Toyoda T, Mori A, Tanaka H, Maekita T, et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 2010;70(4):1430\u201340. https:\/\/doi.org\/10.1158\/0008-5472.Can-09-2755.","journal-title":"Cancer Res"},{"issue":"4","key":"473_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00904-23","volume":"11","author":"K Yue","year":"2023","unstructured":"Yue K, Sheng D, Xue X, Zhao L, Zhao G, Jin C, et al. Bidirectional mediation effects between intratumoral microbiome and host DNA methylation changes contribute to stomach adenocarcinoma. Microbiol Spectr. 2023;11(4):e0090423. https:\/\/doi.org\/10.1128\/spectrum.00904-23.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"473_CR58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40168-020-00847-4","volume":"8","author":"X Xia","year":"2020","unstructured":"Xia X, Wu WKK, Wong SH, Liu D, Kwong TNY, Nakatsu G, et al. Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer. Microbiome. 2020;8(1):108. https:\/\/doi.org\/10.1186\/s40168-020-00847-4.","journal-title":"Microbiome"},{"issue":"1","key":"473_CR59","doi-asserted-by":"publisher","first-page":"2363012","DOI":"10.1080\/19490976.2024.2363012","volume":"16","author":"PH Park","year":"2024","unstructured":"Park PH, Keith K, Calendo G, Jelinek J, Madzo J, Gharaibeh RZ, et al. Association between gut microbiota and CpG island methylator phenotype in colorectal cancer. Gut Microbes. 2024;16(1):2363012. https:\/\/doi.org\/10.1080\/19490976.2024.2363012.","journal-title":"Gut Microbes"},{"key":"473_CR60","doi-asserted-by":"publisher","unstructured":"Hong J, Guo F, Lu SY, Shen C, Ma D, Zhang X, et al. F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer. Gut. 2021;70(11):2123\u201337. https:\/\/doi.org\/10.1136\/gutjnl-2020-322780","DOI":"10.1136\/gutjnl-2020-322780"},{"issue":"1","key":"473_CR61","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.2022407","volume":"14","author":"V Woo","year":"2022","unstructured":"Woo V, Alenghat T. Epigenetic regulation by gut microbiota. Gut Microbes. 2022;14(1):2022407. https:\/\/doi.org\/10.1080\/19490976.2021.2022407.","journal-title":"Gut Microbes"},{"issue":"38","key":"473_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202405331","volume":"36","author":"F Peng","year":"2024","unstructured":"Peng F, Hu M, Su Z, Hu L, Guo L, Yang K. Intratumoral microbiota as a target for advanced cancer therapeutics. Adv Mater. 2024;36(38):e2405331. https:\/\/doi.org\/10.1002\/adma.202405331.","journal-title":"Adv Mater"},{"issue":"1","key":"473_CR63","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1080\/22221751.2021.2006580","volume":"10","author":"A Kostyusheva","year":"2021","unstructured":"Kostyusheva A, Brezgin S, Glebe D, Kostyushev D, Chulanov V. Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification. Emerg Microbes Infect. 2021;10(1):2264\u201375. https:\/\/doi.org\/10.1080\/22221751.2021.2006580.","journal-title":"Emerg Microbes Infect"},{"key":"473_CR64","doi-asserted-by":"publisher","unstructured":"Li N, Xu X, Zhan Y, Fei X, Ouyang Y, Zheng P, et al. YAP and \u03b2-catenin cooperate to drive H. pylori-induced gastric tumorigenesis. Gut Microbes. 2023;15(1):2192501. https:\/\/doi.org\/10.1080\/19490976.2023.2192501","DOI":"10.1080\/19490976.2023.2192501"},{"issue":"1","key":"473_CR65","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2391521","volume":"16","author":"M Sun","year":"2024","unstructured":"Sun M, Peng Z, Shen W, Guo X, Liao Y, Huang Y, et al. Synergism of Fusobacterium periodonticum and N-nitrosamines promote the formation of EMT subtypes in ESCC by modulating Wnt3a palmitoylation. Gut Microbes. 2024;16(1):2391521. https:\/\/doi.org\/10.1080\/19490976.2024.2391521.","journal-title":"Gut Microbes"},{"issue":"2","key":"473_CR66","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14(2):195\u2013206. https:\/\/doi.org\/10.1016\/j.chom.2013.07.012.","journal-title":"Cell Host Microbe"},{"issue":"10","key":"473_CR67","doi-asserted-by":"publisher","first-page":"G1113","DOI":"10.1152\/ajpgi.00453.2011","volume":"303","author":"R Lu","year":"2012","unstructured":"Lu R, Liu X, Wu S, Xia Y, Zhang YG, Petrof EO, et al. Consistent activation of the \u03b2-catenin pathway by Salmonella type-three secretion effector protein AvrA in chronically infected intestine. Am J Physiol Gastrointest Liver Physiol. 2012;303(10):G1113\u201325. https:\/\/doi.org\/10.1152\/ajpgi.00453.2011.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"473_CR68","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2502138","volume":"17","author":"J Deng","year":"2025","unstructured":"Deng J, Zhang J, Su M, Li J, Su Y, Zhong Q, et al. Fusobacterium mortiferum and its metabolite 5-aminovaleric acid promote the development of colorectal cancer in obese individuals through Wnt\/\u03b2-catenin pathway by DKK2. Gut Microbes. 2025;17(1):2502138. https:\/\/doi.org\/10.1080\/19490976.2025.2502138.","journal-title":"Gut Microbes"},{"key":"473_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107897","volume":"219","author":"J Yu","year":"2025","unstructured":"Yu J, Lu W, Chen Y, Li Y, Yang J, Cai Z, et al. Butyrate derived from intratumoral microbiome facilitates pulmonary metastasis in osteosarcoma. Pharmacol Res. 2025;219:107897. https:\/\/doi.org\/10.1016\/j.phrs.2025.107897.","journal-title":"Pharmacol Res"},{"key":"473_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.584798","volume":"10","author":"W Mu","year":"2020","unstructured":"Mu W, Jia Y, Chen X, Li H, Wang Z, Cheng B. Intracellular Porphyromonas gingivalis promotes the proliferation of colorectal cancer cells via the MAPK\/ERK signaling pathway. Front Cell Infect Microbiol. 2020;10:584798. https:\/\/doi.org\/10.3389\/fcimb.2020.584798.","journal-title":"Front Cell Infect Microbiol"},{"key":"473_CR71","doi-asserted-by":"publisher","unstructured":"Khan AA, Bano Y. Salmonella enterica subsp. enterica host-pathogen interactions and their implications in gallbladder cancer. Microb Pathog. 2021;157:105011. https:\/\/doi.org\/10.1016\/j.micpath.2021.105011","DOI":"10.1016\/j.micpath.2021.105011"},{"issue":"4","key":"473_CR72","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.7150\/ijbs.102742","volume":"21","author":"Y Chen","year":"2025","unstructured":"Chen Y, Qin Y, Fan T, Qiu C, Zhang Y, Dai M, et al. Solobacterium moorei promotes tumor progression via the Integrin \u03b12\/\u03b21-PI3K-AKT-mTOR-C-myc signaling pathway in colorectal cancer. Int J Biol Sci. 2025;21(4):1497\u2013512. https:\/\/doi.org\/10.7150\/ijbs.102742.","journal-title":"Int J Biol Sci"},{"issue":"9","key":"473_CR73","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1164\/rccm.201710-2118OC","volume":"198","author":"JJ Tsay","year":"2018","unstructured":"Tsay JJ, Wu BG, Badri MH, Clemente JC, Shen N, Meyn P, et al. Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer. Am J Respir Crit Care Med. 2018;198(9):1188\u201398. https:\/\/doi.org\/10.1164\/rccm.201710-2118OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"473_CR74","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, et al. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther. 2023;8(1):204. https:\/\/doi.org\/10.1038\/s41392-023-01468-7.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"473_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72594-3","volume":"10","author":"JY Piao","year":"2020","unstructured":"Piao JY, Kim SJ, Kim DH, Park JH, Park SA, Han HJ, et al. Helicobacter pylori infection induces STAT3 phosphorylation on Ser727 and autophagy in human gastric epithelial cells and mouse stomach. Sci Rep. 2020;10(1):15711. https:\/\/doi.org\/10.1038\/s41598-020-72594-3.","journal-title":"Sci Rep"},{"issue":"2","key":"473_CR76","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","volume":"14","author":"AD Kostic","year":"2013","unstructured":"Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207\u201315. https:\/\/doi.org\/10.1016\/j.chom.2013.07.007.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"473_CR77","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.gastro.2016.11.018","volume":"152","author":"Y Yang","year":"2017","unstructured":"Yang Y, Weng W, Peng J, Hong L, Yang L, Toiyama Y, et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating Toll-Like Receptor 4 signaling to Nuclear Factor-\u03baB, and up-regulating expression of MicroRNA-21. Gastroenterology. 2017;152(4):851-66.e24. https:\/\/doi.org\/10.1053\/j.gastro.2016.11.018.","journal-title":"Gastroenterology"},{"issue":"1","key":"473_CR78","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2295384","volume":"16","author":"C Martin-Gallausiaux","year":"2024","unstructured":"Martin-Gallausiaux C, Salesse L, Garcia-Weber D, Marinelli L, Beguet-Crespel F, Brochard V, et al. Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1\/TIFA axis activation. Gut Microbes. 2024;16(1):2295384. https:\/\/doi.org\/10.1080\/19490976.2023.2295384.","journal-title":"Gut Microbes"},{"issue":"1","key":"473_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0985-y","volume":"38","author":"S Zhang","year":"2019","unstructured":"Zhang S, Yang Y, Weng W, Guo B, Cai G, Ma Y, et al. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. J Exp Clin Cancer Res. 2019;38(1):14. https:\/\/doi.org\/10.1186\/s13046-018-0985-y.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"473_CR80","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/s41564-024-01695-w","volume":"9","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wong CC, Ding Y, Gao M, Wen J, Lau HC, et al. Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice. Nat Microbiol. 2024;9(6):1467\u201382. https:\/\/doi.org\/10.1038\/s41564-024-01695-w.","journal-title":"Nat Microbiol"},{"issue":"10","key":"473_CR81","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1158\/2159-8290.Cd-21-0324","volume":"11","author":"RJ Knippel","year":"2021","unstructured":"Knippel RJ, Drewes JL, Sears CL. The cancer microbiome: recent highlights and knowledge gaps. Cancer Discov. 2021;11(10):2378\u201395. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0324.","journal-title":"Cancer Discov"},{"issue":"7777","key":"473_CR82","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","volume":"574","author":"B Aykut","year":"2019","unstructured":"Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim JI, et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 2019;574(7777):264\u20137. https:\/\/doi.org\/10.1038\/s41586-019-1608-2.","journal-title":"Nature"},{"key":"473_CR83","doi-asserted-by":"publisher","unstructured":"Sun J, Tang Q, Yu S, Xie M, Zheng W, Chen G, et al. F.\u00a0nucleatum facilitates oral squamous cell carcinoma progression via GLUT1-driven lactate production. EBioMedicine. 2023;88:104444. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104444","DOI":"10.1016\/j.ebiom.2023.104444"},{"issue":"24","key":"473_CR84","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.1158\/0008-5472.Can-21-2273","volume":"81","author":"X Zheng","year":"2021","unstructured":"Zheng X, Liu R, Zhou C, Yu H, Luo W, Zhu J, et al. ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of Fusobacterium nucleatum in Colorectal Cancer. Cancer Res. 2021;81(24):6157\u201370. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-2273.","journal-title":"Cancer Res"},{"issue":"12","key":"473_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105222","volume":"9","author":"H Liu","year":"2022","unstructured":"Liu H, Du J, Chao S, Li S, Cai H, Zhang H, et al. Fusobacterium nucleatum Promotes Colorectal Cancer Cell to Acquire Stem Cell-Like Features by Manipulating Lipid Droplet-Mediated Numb Degradation. Adv Sci (Weinh). 2022;9(12):e2105222. https:\/\/doi.org\/10.1002\/advs.202105222.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"473_CR86","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41392-025-02197-9","volume":"10","author":"Q Xiao","year":"2025","unstructured":"Xiao Q, Liu Y, Li T, Wang C, He S, Zhai L, et al. Viral oncogenesis in cancer: from mechanisms to therapeutics. Signal Transduct Target Ther. 2025;10(1):151. https:\/\/doi.org\/10.1038\/s41392-025-02197-9.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"473_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006020","volume":"12","author":"C Berrios","year":"2016","unstructured":"Berrios C, Padi M, Keibler MA, Park DE, Molla V, Cheng J, et al. Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation. PLoS Pathog. 2016;12(11):e1006020. https:\/\/doi.org\/10.1371\/journal.ppat.1006020.","journal-title":"PLoS Pathog"},{"key":"473_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00401","volume":"3","author":"AP Bhatt","year":"2012","unstructured":"Bhatt AP, Damania B. AKTivation of PI3K\/AKT\/mTOR signaling pathway by KSHV. Front Immunol. 2012;3:401. https:\/\/doi.org\/10.3389\/fimmu.2012.00401.","journal-title":"Front Immunol"},{"key":"473_CR89","doi-asserted-by":"publisher","unstructured":"Xi Y, Lindenmayer L, Kline I, von Einem J, Purdy JG. Human Cytomegalovirus Uses a Host Stress Response To Balance the Elongation of Saturated\/Monounsaturated and Polyunsaturated Very-Long-Chain Fatty Acids. mBio. 2021;12(3). https:\/\/doi.org\/10.1128\/mBio.00167-21","DOI":"10.1128\/mBio.00167-21"},{"issue":"7","key":"473_CR90","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.tim.2011.04.002","volume":"19","author":"Y Yu","year":"2011","unstructured":"Yu Y, Clippinger AJ, Alwine JC. Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection. Trends Microbiol. 2011;19(7):360\u20137. https:\/\/doi.org\/10.1016\/j.tim.2011.04.002.","journal-title":"Trends Microbiol"},{"key":"473_CR91","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ebiom.2019.04.028","volume":"44","author":"ZE Ilhan","year":"2019","unstructured":"Ilhan ZE, \u0141aniewski P, Thomas N, Roe DJ, Chase DM, Herbst-Kralovetz MM. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling. EBioMedicine. 2019;44:675\u201390. https:\/\/doi.org\/10.1016\/j.ebiom.2019.04.028.","journal-title":"EBioMedicine"},{"issue":"12","key":"473_CR92","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41419-021-04396-y","volume":"12","author":"D Dai","year":"2021","unstructured":"Dai D, Yang Y, Yu J, Dang T, Qin W, Teng L, et al. Interactions between gastric microbiota and metabolites in gastric cancer. Cell Death Dis. 2021;12(12):1104. https:\/\/doi.org\/10.1038\/s41419-021-04396-y.","journal-title":"Cell Death Dis"},{"issue":"6024","key":"473_CR93","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331(6024):1559\u201364. https:\/\/doi.org\/10.1126\/science.1203543.","journal-title":"Science"},{"key":"473_CR94","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321187","author":"S Guo","year":"2020","unstructured":"Guo S, Chen J, Chen F, Zeng Q, Liu WL, Zhang G. Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246\/92b-3p\/27a-3p and CXCL16. Gut. 2020. https:\/\/doi.org\/10.1136\/gutjnl-2020-321187.","journal-title":"Gut"},{"issue":"1","key":"473_CR95","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12929-024-01097-4","volume":"32","author":"Y Yu","year":"2025","unstructured":"Yu Y, Yin H, Wu B, Zhao W, Wang Y, Aili A, et al. Fusobacterium nucleatum promotes colorectal cancer liver metastasis via miR-5692a\/IL-8 axis by inducing epithelial-mesenchymal transition. J Biomed Sci. 2025;32(1):5. https:\/\/doi.org\/10.1186\/s12929-024-01097-4.","journal-title":"J Biomed Sci"},{"issue":"17","key":"473_CR96","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1158\/0008-5472.Can-21-0453","volume":"81","author":"C Kong","year":"2021","unstructured":"Kong C, Yan X, Zhu Y, Zhu H, Luo Y, Liu P, et al. Fusobacterium Nucleatum Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450\/Epoxyoctadecenoic Acid Axis via TLR4\/Keap1\/NRF2 Signaling. Cancer Res. 2021;81(17):4485\u201398. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-0453.","journal-title":"Cancer Res"},{"issue":"1","key":"473_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011096","volume":"19","author":"Y Wu","year":"2023","unstructured":"Wu Y, Guo S, Chen F, Li Y, Huang Y, Liu W, et al. Fn-Dps, a novel virulence factor of Fusobacterium nucleatum, disrupts erythrocytes and promotes metastasis in colorectal cancer. PLoS Pathog. 2023;19(1):e1011096. https:\/\/doi.org\/10.1371\/journal.ppat.1011096.","journal-title":"PLoS Pathog"},{"issue":"1","key":"473_CR98","doi-asserted-by":"publisher","first-page":"2446376","DOI":"10.1080\/19490976.2024.2446376","volume":"17","author":"Y Dong","year":"2025","unstructured":"Dong Y, Meng F, Wang J, Wei J, Zhang K, Qin S, et al. Desulfovibrio vulgaris flagellin exacerbates colorectal cancer through activating LRRC19\/TRAF6\/TAK1 pathway. Gut Microbes. 2025;17(1):2446376. https:\/\/doi.org\/10.1080\/19490976.2024.2446376.","journal-title":"Gut Microbes"},{"issue":"6","key":"473_CR99","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.chom.2025.05.004","volume":"33","author":"X Ding","year":"2025","unstructured":"Ding X, Ting NL, Wong CC, Huang P, Jiang L, Liu C, et al. Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity. Cell Host Microbe. 2025;33(6):941-56.e10. https:\/\/doi.org\/10.1016\/j.chom.2025.05.004.","journal-title":"Cell Host Microbe"},{"issue":"32","key":"473_CR100","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1038\/onc.2013.380","volume":"33","author":"E Bess\u00e8de","year":"2014","unstructured":"Bess\u00e8de E, Staedel C, Acu\u00f1a Amador LA, Nguyen PH, Chambonnier L, Hatakeyama M, et al. Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes. Oncogene. 2014;33(32):4123\u201331. https:\/\/doi.org\/10.1038\/onc.2013.380.","journal-title":"Oncogene"},{"key":"473_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153649","author":"WT Li","year":"2021","unstructured":"Li WT, Iyangar AS, Reddy R, Chakladar J, Bhargava V, Sakamoto K, et al. The bladder microbiome is associated with epithelial-mesenchymal transition in muscle invasive urothelial bladder carcinoma. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13153649.","journal-title":"Cancers (Basel)"},{"key":"473_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00493","volume":"7","author":"J Lee","year":"2017","unstructured":"Lee J, Roberts JS, Atanasova KR, Chowdhury N, Han K, Yilmaz \u00d6. Human primary epithelial cells acquire an epithelial-mesenchymal-transition phenotype during long-term infection by the oral opportunistic pathogen, Porphyromonas gingivalis. Front Cell Infect Microbiol. 2017;7:493. https:\/\/doi.org\/10.3389\/fcimb.2017.00493.","journal-title":"Front Cell Infect Microbiol"},{"key":"473_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092524","author":"J Ma","year":"2020","unstructured":"Ma J, Gnanasekar A, Lee A, Li WT, Haas M, Wang-Rodriguez J, et al. Influence of intratumor microbiome on clinical outcome and immune processes in prostate cancer. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12092524.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"473_CR104","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41416-018-0143-5","volume":"119","author":"AK Kylm\u00e4","year":"2018","unstructured":"Kylm\u00e4 AK, Jouhi L, Listyarifah D, Mohamed H, M\u00e4kitie A, Remes SM, et al. Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma. Br J Cancer. 2018;119(1):89\u201395. https:\/\/doi.org\/10.1038\/s41416-018-0143-5.","journal-title":"Br J Cancer"},{"issue":"3","key":"473_CR105","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/bjc.2017.409","volume":"118","author":"MT Nieminen","year":"2018","unstructured":"Nieminen MT, Listyarifah D, Hagstr\u00f6m J, Haglund C, Grenier D, Nordstr\u00f6m D, et al. Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation. Br J Cancer. 2018;118(3):428\u201334. https:\/\/doi.org\/10.1038\/bjc.2017.409.","journal-title":"Br J Cancer"},{"key":"473_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-018-0208-3","volume":"13","author":"N Hemmat","year":"2018","unstructured":"Hemmat N, Baghi HB. Human papillomavirus E5 protein, the undercover culprit of tumorigenesis. Infect Agent Cancer. 2018;13:31. https:\/\/doi.org\/10.1186\/s13027-018-0208-3.","journal-title":"Infect Agent Cancer"},{"issue":"2","key":"473_CR107","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42(2):344\u201355. https:\/\/doi.org\/10.1016\/j.immuni.2015.01.010.","journal-title":"Immunity"},{"issue":"6","key":"473_CR108","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2019.1581531","volume":"8","author":"C Gur","year":"2019","unstructured":"Gur C, Maalouf N, Shhadeh A, Berhani O, Singer BB, Bachrach G, et al. Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1. Oncoimmunology. 2019;8(6):e1581531. https:\/\/doi.org\/10.1080\/2162402x.2019.1581531.","journal-title":"Oncoimmunology"},{"issue":"1","key":"473_CR109","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s40168-024-01907-9","volume":"12","author":"J Zhou","year":"2024","unstructured":"Zhou J, Hu Z, Wang L, Hu Q, Chen Z, Lin T, et al. Tumor-colonized Streptococcus mutans metabolically reprograms tumor microenvironment and promotes oral squamous cell carcinoma. Microbiome. 2024;12(1):193. https:\/\/doi.org\/10.1186\/s40168-024-01907-9.","journal-title":"Microbiome"},{"issue":"2","key":"473_CR110","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.102","volume":"2","author":"Y Li","year":"2023","unstructured":"Li Y, Zhang D, Wang M, Jiang H, Feng C, Li YX. Intratumoral microbiota is associated with prognosis in patients with adrenocortical carcinoma. iMeta. 2023;2(2):e102. https:\/\/doi.org\/10.1002\/imt2.102.","journal-title":"iMeta"},{"issue":"1","key":"473_CR111","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41467-020-16079-x","volume":"11","author":"C Coutzac","year":"2020","unstructured":"Coutzac C, Jouniaux JM, Paci A, Schmidt J, Mallardo D, Seck A, et al. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nat Commun. 2020;11(1):2168. https:\/\/doi.org\/10.1038\/s41467-020-16079-x.","journal-title":"Nat Commun"},{"issue":"4","key":"473_CR112","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.chom.2017.03.003","volume":"21","author":"LN Segal","year":"2017","unstructured":"Segal LN, Clemente JC, Li Y, Ruan C, Cao J, Danckers M, et al. Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients. Cell Host Microbe. 2017;21(4):530-7.e4. https:\/\/doi.org\/10.1016\/j.chom.2017.03.003.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"473_CR113","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s42255-022-00558-0","volume":"4","author":"D Ternes","year":"2022","unstructured":"Ternes D, Tsenkova M, Pozdeev VI, Meyers M, Koncina E, Atatri S, et al. The gut microbial metabolite formate exacerbates colorectal cancer progression. Nat Metab. 2022;4(4):458\u201375. https:\/\/doi.org\/10.1038\/s42255-022-00558-0.","journal-title":"Nat Metab"},{"issue":"24","key":"473_CR114","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1038\/s41388-025-03439-4","volume":"44","author":"J Gu","year":"2025","unstructured":"Gu J, Xu X, Li X, Yue L, Zhu X, Chen Q, et al. Correction: Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation. Oncogene. 2025;44(24):2004\u20137. https:\/\/doi.org\/10.1038\/s41388-025-03439-4.","journal-title":"Oncogene"},{"issue":"5","key":"473_CR115","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1128\/iai.01226-13","volume":"82","author":"SR Park","year":"2014","unstructured":"Park SR, Kim DJ, Han SH, Kang MJ, Lee JY, Jeong YJ, et al. Diverse toll-like receptors mediate cytokine production by Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans in macrophages. Infect Immun. 2014;82(5):1914\u201320. https:\/\/doi.org\/10.1128\/iai.01226-13.","journal-title":"Infect Immun"},{"issue":"10","key":"473_CR116","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00262-018-2233-x","volume":"67","author":"T Chen","year":"2018","unstructured":"Chen T, Li Q, Wu J, Wu Y, Peng W, Li H, et al. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism. Cancer Immunol Immunother. 2018;67(10):1635\u201346. https:\/\/doi.org\/10.1007\/s00262-018-2233-x.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"473_CR117","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.immuni.2018.08.018","volume":"49","author":"T Wang","year":"2018","unstructured":"Wang T, Fan C, Yao A, Xu X, Zheng G, You Y, et al. The adaptor protein CARD9 protects against colon cancer by restricting mycobiota-mediated expansion of myeloid-derived suppressor cells. Immunity. 2018;49(3):504-14.e4. https:\/\/doi.org\/10.1016\/j.immuni.2018.08.018.","journal-title":"Immunity"},{"issue":"2","key":"473_CR118","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"K Hezaveh","year":"2022","unstructured":"Hezaveh K, Shinde RS, Kl\u00f6tgen A, Halaby MJ, Lamorte S, Ciudad MT, et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 2022;55(2):324-40.e8. https:\/\/doi.org\/10.1016\/j.immuni.2022.01.006.","journal-title":"Immunity"},{"issue":"5","key":"473_CR119","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","volume":"34","author":"T Kawai","year":"2011","unstructured":"Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34(5):637\u201350. https:\/\/doi.org\/10.1016\/j.immuni.2011.05.006.","journal-title":"Immunity"},{"issue":"2","key":"473_CR120","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.chom.2018.01.007","volume":"23","author":"L Chung","year":"2018","unstructured":"Chung L, Thiele Orberg E, Geis AL, Chan JL, Fu K, DeStefano Shields CE, et al. Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. Cell Host Microbe. 2018;23(2):203-14.e5. https:\/\/doi.org\/10.1016\/j.chom.2018.01.007.","journal-title":"Cell Host Microbe"},{"issue":"5","key":"473_CR121","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","volume":"40","author":"P Wu","year":"2014","unstructured":"Wu P, Wu D, Ni C, Ye J, Chen W, Hu G, et al. \u03b3\u03b4T17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity. 2014;40(5):785\u2013800. https:\/\/doi.org\/10.1016\/j.immuni.2014.03.013.","journal-title":"Immunity"},{"issue":"8","key":"473_CR122","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/gutjnl-2020-320777","volume":"70","author":"Y Yang","year":"2020","unstructured":"Yang Y, Li L, Xu C, Wang Y, Wang Z, Chen M, et al. Cross-talk between the gut microbiota and monocyte-like macrophages mediates an inflammatory response to promote colitis-associated tumourigenesis. Gut. 2020;70(8):1495\u2013506. https:\/\/doi.org\/10.1136\/gutjnl-2020-320777.","journal-title":"Gut"},{"key":"473_CR123","doi-asserted-by":"publisher","unstructured":"Liu Q, Wang J, Yao Y, Sun X, Fang W, Zhang Y, et al. Intratumor Rhodococcus sp. B513 drives DEN-induced hepatocellular carcinoma progression by modulating gut microbiota and angiogenesis. Curr Res Microb Sci. 2025;9:100428. https:\/\/doi.org\/10.1016\/j.crmicr.2025.100428","DOI":"10.1016\/j.crmicr.2025.100428"},{"issue":"4","key":"473_CR124","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00432-024-05730-5","volume":"150","author":"Y Qin","year":"2024","unstructured":"Qin Y, Li Z, Liu T, Ma J, Liu H, Zhou Y, et al. Prevotella intermedia boosts OSCC progression through ISG15 upregulation: a new target for intervention. J Cancer Res Clin Oncol. 2024;150(4):206. https:\/\/doi.org\/10.1007\/s00432-024-05730-5.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"473_CR125","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/1040841x.2020.1843400","volume":"47","author":"NO Ponde","year":"2021","unstructured":"Ponde NO, Lortal L, Ramage G, Naglik JR, Richardson JP. Candida albicans biofilms and polymicrobial interactions. Crit Rev Microbiol. 2021;47(1):91\u2013111. https:\/\/doi.org\/10.1080\/1040841x.2020.1843400.","journal-title":"Crit Rev Microbiol"},{"issue":"10","key":"473_CR126","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1111\/mec.16411","volume":"32","author":"J MacAlpine","year":"2023","unstructured":"MacAlpine J, Robbins N, Cowen LE. Bacterial-fungal interactions and their impact on microbial pathogenesis. Mol Ecol. 2023;32(10):2565\u201381. https:\/\/doi.org\/10.1111\/mec.16411.","journal-title":"Mol Ecol"},{"issue":"8","key":"473_CR127","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009794","volume":"17","author":"KA Morelli","year":"2021","unstructured":"Morelli KA, Kerkaert JD, Cramer RA. Aspergillus fumigatus biofilms: toward understanding how growth as a multicellular network increases antifungal resistance and disease progression. PLoS Pathog. 2021;17(8):e1009794. https:\/\/doi.org\/10.1371\/journal.ppat.1009794.","journal-title":"PLoS Pathog"},{"key":"473_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/jof8111209","author":"E \u010conkov\u00e1","year":"2022","unstructured":"\u010conkov\u00e1 E, Pro\u0161kovcov\u00e1 M, V\u00e1czi P, Malinovsk\u00e1 Z. In vitro biofilm formation by Malassezia pachydermatis isolates and its susceptibility to azole antifungals. J Fungi (Basel). 2022. https:\/\/doi.org\/10.3390\/jof8111209.","journal-title":"J Fungi (Basel)"},{"key":"473_CR129","doi-asserted-by":"publisher","unstructured":"Camacho E, Casadevall A. Cryptococcal Traits Mediating Adherence to Biotic and Abiotic Surfaces. J Fungi (Basel). 2018;4(3). https:\/\/doi.org\/10.3390\/jof4030088","DOI":"10.3390\/jof4030088"},{"issue":"1","key":"473_CR130","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/mmy\/myx014","volume":"56","author":"L Angiolella","year":"2018","unstructured":"Angiolella L, Leone C, Rojas F, Mussin J, de Los Angeles Sosa M, Giusiano G. Biofilm, adherence, and hydrophobicity as virulence factors in Malassezia furfur. Med Mycol. 2018;56(1):110\u20136. https:\/\/doi.org\/10.1093\/mmy\/myx014.","journal-title":"Med Mycol"},{"issue":"6356","key":"473_CR131","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357(6356):1156\u201360. https:\/\/doi.org\/10.1126\/science.aah5043.","journal-title":"Science"},{"issue":"7","key":"473_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111625","volume":"41","author":"KD LaCourse","year":"2022","unstructured":"LaCourse KD, Zepeda-Rivera M, Kempchinsky AG, Baryiames A, Minot SS, Johnston CD, et al. The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota. Cell Rep. 2022;41(7):111625. https:\/\/doi.org\/10.1016\/j.celrep.2022.111625.","journal-title":"Cell Rep"},{"issue":"4","key":"473_CR133","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1053\/j.gastro.2020.09.003","volume":"160","author":"Q Li","year":"2021","unstructured":"Li Q, Hu W, Liu WX, Zhao LY, Huang D, Liu XD, et al. Streptococcus thermophilus Inhibits Colorectal Tumorigenesis Through Secreting \u03b2-Galactosidase. Gastroenterology. 2021;160(4):1179-93.e14. https:\/\/doi.org\/10.1053\/j.gastro.2020.09.003.","journal-title":"Gastroenterology"},{"issue":"2","key":"473_CR134","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00262-022-03256-8","volume":"72","author":"Z Hexun","year":"2023","unstructured":"Hexun Z, Miyake T, Maekawa T, Mori H, Yasukawa D, Ohno M, et al. High abundance of Lachnospiraceae in the human gut microbiome is related to high immunoscores in advanced colorectal cancer. Cancer Immunol Immunother. 2023;72(2):315\u201326. https:\/\/doi.org\/10.1007\/s00262-022-03256-8.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"473_CR135","doi-asserted-by":"publisher","first-page":"2156255","DOI":"10.1080\/19490976.2022.2156255","volume":"15","author":"X Chai","year":"2023","unstructured":"Chai X, Wang J, Li H, Gao C, Li S, Wei C, et al. Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma. Gut Microbes. 2023;15(1):2156255. https:\/\/doi.org\/10.1080\/19490976.2022.2156255.","journal-title":"Gut Microbes"},{"issue":"6","key":"473_CR136","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s13402-023-00831-8","volume":"46","author":"X Yang","year":"2023","unstructured":"Yang X, Zhang Z, Shen X, Xu J, Weng Y, Wang W, et al. Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma. Cell Oncol (Dordr). 2023;46(6):1645\u201358. https:\/\/doi.org\/10.1007\/s13402-023-00831-8.","journal-title":"Cell Oncol (Dordr)"},{"key":"473_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107902","volume":"219","author":"X Li","year":"2025","unstructured":"Li X, Wang Y, Wu Y, Wang J, Qi Y, Bi X. Intratumor microbiome-derived butyrate enhances progesterone sensitivity by inducing ferroptosis in endometrial cancer. Pharmacol Res. 2025;219:107902. https:\/\/doi.org\/10.1016\/j.phrs.2025.107902.","journal-title":"Pharmacol Res"},{"issue":"13","key":"473_CR138","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1007\/s00253-020-10621-z","volume":"104","author":"Q Wang","year":"2020","unstructured":"Wang Q, Wang K, Wu W, Lv L, Bian X, Yang L, et al. Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)\/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice. Appl Microbiol Biotechnol. 2020;104(13):5915\u201328. https:\/\/doi.org\/10.1007\/s00253-020-10621-z.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"7","key":"473_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28093","volume":"10","author":"R Bi","year":"2024","unstructured":"Bi R, Jiang L, Hu R, Wen B, Jiang Z, Liu H, et al. Butyrate attenuates the stemness of lung cancer cells through lysosome Fe(2+)- and SLC7A11-mediated ferroptosis. Heliyon. 2024;10(7):e28093. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28093.","journal-title":"Heliyon"},{"key":"473_CR140","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2024.01.005","volume":"213","author":"Y Wei","year":"2024","unstructured":"Wei Y, Liu W, Wang R, Chen Y, Liu J, Guo X, et al. Propionate promotes ferroptosis and apoptosis through mitophagy and ACSL4-mediated ferroptosis elicits anti-leukemia immunity. Free Radic Biol Med. 2024;213:36\u201351. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.01.005.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"473_CR141","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cmet.2022.02.010","volume":"34","author":"H Wang","year":"2022","unstructured":"Wang H, Rong X, Zhao G, Zhou Y, Xiao Y, Ma D, et al. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer. Cell Metab. 2022;34(4):581-94.e8. https:\/\/doi.org\/10.1016\/j.cmet.2022.02.010.","journal-title":"Cell Metab"},{"key":"473_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123729","author":"L Boyero","year":"2020","unstructured":"Boyero L, S\u00e1nchez-Gastaldo A, Alonso M, Noguera-Ucl\u00e9s JF, Molina-Pinelo S, Bernab\u00e9-Caro R. Primary and acquired resistance to immunotherapy in lung cancer: unveiling the mechanisms underlying of immune checkpoint blockade therapy. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12123729.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"473_CR143","doi-asserted-by":"publisher","first-page":"886","DOI":"10.22038\/ijbms.2020.43016.10115","volume":"23","author":"S Alizadeh","year":"2020","unstructured":"Alizadeh S, Esmaeili A, Omidi Y. Anti-cancer properties of Escherichia coli Nissle 1917 against HT-29 colon cancer cells through regulation of Bax\/Bcl-xL and AKT\/PTEN signaling pathways. Iran J Basic Med Sci. 2020;23(7):886\u201393. https:\/\/doi.org\/10.22038\/ijbms.2020.43016.10115.","journal-title":"Iran J Basic Med Sci"},{"issue":"8","key":"473_CR144","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.ccell.2023.06.011","volume":"41","author":"Q Li","year":"2023","unstructured":"Li Q, Chan H, Liu WX, Liu CA, Zhou Y, Huang D, et al. Carnobacterium maltaromaticum boosts intestinal Vitamin D production to suppress colorectal cancer in female mice. Cancer Cell. 2023;41(8):1450-65.e8. https:\/\/doi.org\/10.1016\/j.ccell.2023.06.011.","journal-title":"Cancer Cell"},{"key":"473_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phymed.2017.08.019","volume":"35","author":"M Seifrtov\u00e1","year":"2017","unstructured":"Seifrtov\u00e1 M, Havelek R, Cahl\u00edkov\u00e1 L, Hulcov\u00e1 D, Maz\u00e1nkov\u00e1 N, \u0158ez\u00e1\u010dov\u00e1 M. Haemanthamine alters sodium butyrate-induced histone acetylation, p21(WAF1\/Cip1) expression, Chk1 and Chk2 activation and leads to increased growth inhibition and death in A2780 ovarian cancer cells. Phytomedicine. 2017;35:1\u201310. https:\/\/doi.org\/10.1016\/j.phymed.2017.08.019.","journal-title":"Phytomedicine"},{"issue":"1","key":"473_CR146","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2449111","volume":"17","author":"Y Sun","year":"2025","unstructured":"Sun Y, Wang Q, Jiang Y, He J, Jia D, Luo M, et al. Lactobacillus intestinalis facilitates tumor-derived CCL5 to recruit dendritic cell and suppress colorectal tumorigenesis. Gut Microbes. 2025;17(1):2449111. https:\/\/doi.org\/10.1080\/19490976.2024.2449111.","journal-title":"Gut Microbes"},{"issue":"12","key":"473_CR147","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1136\/gutjnl-2023-329543","volume":"72","author":"W Fong","year":"2023","unstructured":"Fong W, Li Q, Ji F, Liang W, Lau HCH, Kang X, et al. Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1\/Kyn\/AHR axis. Gut. 2023;72(12):2272\u201385. https:\/\/doi.org\/10.1136\/gutjnl-2023-329543.","journal-title":"Gut"},{"issue":"6510","key":"473_CR148","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","volume":"369","author":"LF Mager","year":"2020","unstructured":"Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay H, et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 2020;369(6510):1481\u20139. https:\/\/doi.org\/10.1126\/science.abc3421.","journal-title":"Science"},{"issue":"12","key":"473_CR149","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.immuni.2021.11.003","volume":"54","author":"AE Overacre-Delgoffe","year":"2021","unstructured":"Overacre-Delgoffe AE, Bumgarner HJ, Cillo AR, Burr AHP, Tometich JT, Bhattacharjee A, et al. Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer. Immunity. 2021;54(12):2812-24.e4. https:\/\/doi.org\/10.1016\/j.immuni.2021.11.003.","journal-title":"Immunity"},{"issue":"6","key":"473_CR150","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cmet.2023.04.015","volume":"35","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zhao Q, Li T, Lu L, Wang F, Zhang H, et al. Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8(+) T cell immunity. Cell Metab. 2023;35(6):943-60.e9. https:\/\/doi.org\/10.1016\/j.cmet.2023.04.015.","journal-title":"Cell Metab"},{"key":"473_CR151","doi-asserted-by":"publisher","unstructured":"Shi Y, Zheng W, Yang K, Harris KG, Ni K, Xue L, et al. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. J Exp Med. 2020;217(5). https:\/\/doi.org\/10.1084\/jem.20192282","DOI":"10.1084\/jem.20192282"},{"key":"473_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100920","volume":"43","author":"WJ Ma","year":"2023","unstructured":"Ma WJ, Li ZH, Wu ZR, Liu F, Wang JK, Shi YJ, et al. PI3K-CCL2-CCR2-MDSCs axis: A potential pathway for tumor Clostridia-promoted CD 8(+) T lymphocyte infiltration in bile tract cancers. Neoplasia. 2023;43:100920. https:\/\/doi.org\/10.1016\/j.neo.2023.100920.","journal-title":"Neoplasia"},{"issue":"4","key":"473_CR153","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, et al. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell. 2019;178(4):795-806.e12. https:\/\/doi.org\/10.1016\/j.cell.2019.07.008.","journal-title":"Cell"},{"issue":"7852","key":"473_CR154","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41586-021-03368-8","volume":"592","author":"S Kalaora","year":"2021","unstructured":"Kalaora S, Nagler A, Nejman D, Alon M, Barbolin C, Barnea E, et al. Identification of bacteria-derived HLA-bound peptides in melanoma. Nature. 2021;592(7852):138\u201343. https:\/\/doi.org\/10.1038\/s41586-021-03368-8.","journal-title":"Nature"},{"issue":"6506","key":"473_CR155","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1126\/science.aax0701","volume":"369","author":"A Fluckiger","year":"2020","unstructured":"Fluckiger A, Daill\u00e8re R, Sassi M, Sixt BS, Liu P, Loos F, et al. Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage. Science. 2020;369(6506):936\u201342. https:\/\/doi.org\/10.1126\/science.aax0701.","journal-title":"Science"},{"key":"473_CR156","doi-asserted-by":"publisher","unstructured":"Bessell CA, Isser A, Havel JJ, Lee S, Bell DR, Hickey JW, et al. Commensal bacteria stimulate antitumor responses via T cell cross-reactivity. JCI Insight. 2020;5(8). https:\/\/doi.org\/10.1172\/jci.insight.135597","DOI":"10.1172\/jci.insight.135597"},{"issue":"1","key":"473_CR157","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12967-022-03512-6","volume":"20","author":"C Ragone","year":"2022","unstructured":"Ragone C, Manolio C, Mauriello A, Cavalluzzo B, Buonaguro FM, Tornesello ML, et al. Molecular mimicry between tumor associated antigens and microbiota-derived epitopes. J Transl Med. 2022;20(1):316. https:\/\/doi.org\/10.1186\/s12967-022-03512-6.","journal-title":"J Transl Med"},{"issue":"3","key":"473_CR158","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3892\/ijo.2013.1790","volume":"42","author":"M Shinnoh","year":"2013","unstructured":"Shinnoh M, Horinaka M, Yasuda T, Yoshikawa S, Morita M, Yamada T, et al. Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8. Int J Oncol. 2013;42(3):903\u201311. https:\/\/doi.org\/10.3892\/ijo.2013.1790.","journal-title":"Int J Oncol"},{"issue":"1","key":"473_CR159","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11060-023-04318-2","volume":"163","author":"L Ye","year":"2023","unstructured":"Ye L, Wu BS, Xu ZA, Ji XF, Guan L, Li PP, et al. Evidence for an intra-tumoral microbiome in pituitary neuroendocrine tumors with different clinical phenotypes. J Neurooncol. 2023;163(1):133\u201342. https:\/\/doi.org\/10.1007\/s11060-023-04318-2.","journal-title":"J Neurooncol"},{"issue":"10192","key":"473_CR160","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64\u201380. https:\/\/doi.org\/10.1016\/s0140-6736(19)30956-0.","journal-title":"Lancet"},{"issue":"10","key":"473_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101753","volume":"5","author":"S Guo","year":"2024","unstructured":"Guo S, Xing S, Wu Z, Chen F, Pan X, Li Q, et al. Leucine restriction ameliorates Fusobacterium nucleatum-driven malignant progression and radioresistance in nasopharyngeal carcinoma. Cell Rep Med. 2024;5(10):101753. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101753.","journal-title":"Cell Rep Med"},{"issue":"1","key":"473_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45518-2","volume":"15","author":"Y Liao","year":"2024","unstructured":"Liao Y, Wu YX, Tang M, Chen YW, Xie JR, Du Y, et al. Microbes translocation from oral cavity to nasopharyngeal carcinoma in patients. Nat Commun. 2024;15(1):1645. https:\/\/doi.org\/10.1038\/s41467-024-45518-2.","journal-title":"Nat Commun"},{"key":"473_CR163","doi-asserted-by":"publisher","first-page":"191602162413043","DOI":"10.1177\/19160216241304365","volume":"53","author":"YT Lu","year":"2024","unstructured":"Lu YT, Hsin CH, Chuang CY, Huang CC, Su MC, Wen WS, et al. Microbial Dysbiosis in Nasopharyngeal Carcinoma: A Pilot Study on Biomarker Potential. J Otolaryngol Head Neck Surg. 2024;53:19160216241304364. https:\/\/doi.org\/10.1177\/19160216241304365.","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"11","key":"473_CR164","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/s12275-021-1271-9","volume":"59","author":"CJ Liu","year":"2021","unstructured":"Liu CJ, Chen SQ, Zhang SY, Wang JL, Tang XD, Yang KX, et al. The comparison of microbial communities in thyroid tissues from thyroid carcinoma patients. J Microbiol. 2021;59(11):988\u20131001. https:\/\/doi.org\/10.1007\/s12275-021-1271-9.","journal-title":"J Microbiol"},{"issue":"1","key":"473_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03814-x","volume":"5","author":"L Yuan","year":"2022","unstructured":"Yuan L, Yang P, Wei G, Hu X, Chen S, Lu J, et al. Tumor microbiome diversity influences papillary thyroid cancer invasion. Commun Biol. 2022;5(1):864. https:\/\/doi.org\/10.1038\/s42003-022-03814-x.","journal-title":"Commun Biol"},{"issue":"1","key":"473_CR166","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12967-021-03167-9","volume":"19","author":"D Dai","year":"2021","unstructured":"Dai D, Yang Y, Yang Y, Dang T, Xiao J, Wang W, et al. Alterations of thyroid microbiota across different thyroid microhabitats in patients with thyroid carcinoma. J Transl Med. 2021;19(1):488. https:\/\/doi.org\/10.1186\/s12967-021-03167-9.","journal-title":"J Transl Med"},{"key":"473_CR167","doi-asserted-by":"publisher","unstructured":"John D, Yalamarty R, Barakchi A, Chen T, Chakladar J, Li WT, et al. Transcriptomic Analysis Reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma. Int J Mol Sci. 2023;24(4). https:\/\/doi.org\/10.3390\/ijms24043148","DOI":"10.3390\/ijms24043148"},{"issue":"1","key":"473_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-024-00342-8","volume":"17","author":"W Zang","year":"2025","unstructured":"Zang W, Geng F, Liu J, Wang Z, Zhang S, Li Y, et al. Porphyromonas gingivalis potentiates stem-like properties of oral squamous cell carcinoma by modulating SCD1-dependent lipid synthesis via NOD1\/KLF5 axis. Int J Oral Sci. 2025;17(1):15. https:\/\/doi.org\/10.1038\/s41368-024-00342-8.","journal-title":"Int J Oral Sci"},{"issue":"6","key":"473_CR169","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1177\/0022034520909312","volume":"99","author":"L Wen","year":"2020","unstructured":"Wen L, Mu W, Lu H, Wang X, Fang J, Jia Y, et al. Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression in an Immune Microenvironment. J Dent Res. 2020;99(6):666\u201375. https:\/\/doi.org\/10.1177\/0022034520909312.","journal-title":"J Dent Res"},{"key":"473_CR170","doi-asserted-by":"publisher","unstructured":"Lamont RJ, Fitzsimonds ZR, Wang H, Gao S. Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma. Periodontol 2000. 2022;89(1):154\u201365. https:\/\/doi.org\/10.1111\/prd.12425","DOI":"10.1111\/prd.12425"},{"key":"473_CR171","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00476","volume":"9","author":"L Zhang","year":"2019","unstructured":"Zhang L, Liu Y, Zheng HJ, Zhang CP. The oral microbiota may have influence on oral cancer. Front Cell Infect Microbiol. 2019;9:476. https:\/\/doi.org\/10.3389\/fcimb.2019.00476.","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"473_CR172","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1111\/odi.15317","volume":"31","author":"CC Yang","year":"2025","unstructured":"Yang CC, Washio J, Lin YC, Hsu ML, Wang DH, Tsai FT, et al. Microbiome Signatures and Dysbiotic Patterns in Oral Cancer and Precancerous Lesions. Oral Dis. 2025;31(8):2456\u201365. https:\/\/doi.org\/10.1111\/odi.15317.","journal-title":"Oral Dis"},{"key":"473_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104710","volume":"107","author":"Y Li","year":"2020","unstructured":"Li Y, Tan X, Zhao X, Xu Z, Dai W, Duan W, et al. Composition and function of oral microbiota between gingival squamous cell carcinoma and periodontitis. Oral Oncol. 2020;107:104710. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104710.","journal-title":"Oral Oncol"},{"issue":"6","key":"473_CR174","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/0022034518767118","volume":"97","author":"M Perera","year":"2018","unstructured":"Perera M, Al-Hebshi NN, Perera I, Ipe D, Ulett GC, Speicher DJ, et al. Inflammatory bacteriome and oral squamous cell carcinoma. J Dent Res. 2018;97(6):725\u201332. https:\/\/doi.org\/10.1177\/0022034518767118.","journal-title":"J Dent Res"},{"issue":"2","key":"473_CR175","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.job.2019.03.003","volume":"61","author":"Y Takahashi","year":"2019","unstructured":"Takahashi Y, Park J, Hosomi K, Yamada T, Kobayashi A, Yamaguchi Y, et al. Analysis of oral microbiota in Japanese oral cancer patients using 16S rRNA sequencing. J Oral Biosci. 2019;61(2):120\u20138. https:\/\/doi.org\/10.1016\/j.job.2019.03.003.","journal-title":"J Oral Biosci"},{"issue":"10","key":"473_CR176","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1177\/00220345241262759","volume":"103","author":"XX Wang","year":"2024","unstructured":"Wang XX, Liu YT, Ren JG, Liu HM, Fu Q, Yang Y, et al. Salivary Microbiome Relates to Neoadjuvant Immunotherapy Response in OSCC. J Dent Res. 2024;103(10):988\u201398. https:\/\/doi.org\/10.1177\/00220345241262759.","journal-title":"J Dent Res"},{"key":"473_CR177","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fmicb.2018.00862","volume":"9","author":"CY Yang","year":"2018","unstructured":"Yang CY, Yeh YM, Yu HY, Chin CY, Hsu CW, Liu H, et al. Oral Microbiota Community Dynamics Associated With Oral Squamous Cell Carcinoma Staging. Front Microbiol. 2018;9:862. https:\/\/doi.org\/10.3389\/fmicb.2018.00862.","journal-title":"Front Microbiol"},{"issue":"1","key":"473_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57530-1","volume":"16","author":"H Qi","year":"2025","unstructured":"Qi H, Gao H, Li M, Sun T, Gu X, Wei L, et al. Parvimonas micra promotes oral squamous cell carcinoma metastasis through TmpC-CKAP4 axis. Nat Commun. 2025;16(1):2305. https:\/\/doi.org\/10.1038\/s41467-025-57530-1.","journal-title":"Nat Commun"},{"key":"473_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2023.127370","volume":"272","author":"X Wang","year":"2023","unstructured":"Wang X, Zhang W, Wu W, Wu S, Young A, Yan Z. Is Candida albicans a contributor to cancer? A critical review based on the current evidence. Microbiol Res. 2023;272:127370. https:\/\/doi.org\/10.1016\/j.micres.2023.127370.","journal-title":"Microbiol Res"},{"key":"473_CR180","doi-asserted-by":"publisher","unstructured":"Hsieh YP, Wu YH, Cheng SM, Lin FK, Hwang DY, Jiang SS, et al. Single-Cell RNA Sequencing Analysis for Oncogenic Mechanisms Underlying Oral Squamous Cell Carcinoma Carcinogenesis with Candida albicans Infection. Int J Mol Sci. 2022;23(9). https:\/\/doi.org\/10.3390\/ijms23094833","DOI":"10.3390\/ijms23094833"},{"issue":"8","key":"473_CR181","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/odi.12565","volume":"22","author":"AD Alnuaimi","year":"2016","unstructured":"Alnuaimi AD, Ramdzan AN, Wiesenfeld D, O\u2019Brien-Simpson NM, Kolev SD, Reynolds EC, et al. Candida virulence and ethanol-derived acetaldehyde production in oral cancer and non-cancer subjects. Oral Dis. 2016;22(8):805\u201314. https:\/\/doi.org\/10.1111\/odi.12565.","journal-title":"Oral Dis"},{"issue":"29","key":"473_CR182","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1200\/jco.2015.61.6995","volume":"33","author":"ML Gillison","year":"2015","unstructured":"Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of Human Papillomavirus-Positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33(29):3235\u201342. https:\/\/doi.org\/10.1200\/jco.2015.61.6995.","journal-title":"J Clin Oncol"},{"issue":"3","key":"473_CR183","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1007\/s00784-021-04258-z","volume":"26","author":"H J\u00e1come-Santos","year":"2022","unstructured":"J\u00e1come-Santos H, da Silva ESN, Resende RG, Costa Pinheiro HH, Almeida Machado LF, de Souza SG, et al. Simultaneous occurrence of Epstein-Barr virus (EBV) in periodontal pockets and in oral squamous cell carcinoma: a cross-sectional study. Clin Oral Investig. 2022;26(3):2807\u201315. https:\/\/doi.org\/10.1007\/s00784-021-04258-z.","journal-title":"Clin Oral Investig"},{"key":"473_CR184","doi-asserted-by":"publisher","first-page":"1278327","DOI":"10.3389\/fimmu.2024.1278327","volume":"15","author":"M Yan","year":"2024","unstructured":"Yan M, Xiao LY, Gosau M, Smeets R, Feng HC, Burg S, et al. The role of herpes simplex virus infection in the etiology of head and neck cancer-a Mendelian randomization study. Front Immunol. 2024;15:1278327. https:\/\/doi.org\/10.3389\/fimmu.2024.1278327.","journal-title":"Front Immunol"},{"issue":"4","key":"473_CR185","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249832","volume":"16","author":"N Dumont-Leblond","year":"2021","unstructured":"Dumont-Leblond N, Veillette M, Racine C, Joubert P, Duchaine C. Non-small cell lung cancer microbiota characterization: prevalence of enteric and potentially pathogenic bacteria in cancer tissues. PLoS ONE. 2021;16(4):e0249832. https:\/\/doi.org\/10.1371\/journal.pone.0249832.","journal-title":"PLoS ONE"},{"issue":"8","key":"473_CR186","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/carcin\/bgaa044","volume":"41","author":"Q Mao","year":"2020","unstructured":"Mao Q, Ma W, Wang Z, Liang Y, Zhang T, Yang Y, et al. Differential flora in the microenvironment of lung tumor and paired adjacent normal tissues. Carcinogenesis. 2020;41(8):1094\u2013103. https:\/\/doi.org\/10.1093\/carcin\/bgaa044.","journal-title":"Carcinogenesis"},{"issue":"1","key":"473_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-021-02375-z","volume":"21","author":"S Najafi","year":"2021","unstructured":"Najafi S, Abedini F, Azimzadeh Jamalkandi S, Shariati P, Ahmadi A, Gholami Fesharaki M. The composition of lung microbiome in lung cancer: a systematic review and meta-analysis. BMC Microbiol. 2021;21(1):315. https:\/\/doi.org\/10.1186\/s12866-021-02375-z.","journal-title":"BMC Microbiol"},{"issue":"1","key":"473_CR188","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49195-w","volume":"9","author":"S Gomes","year":"2019","unstructured":"Gomes S, Cavadas B, Ferreira JC, Marques PI, Monteiro C, Sucena M, et al. Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma. Sci Rep. 2019;9(1):12838. https:\/\/doi.org\/10.1038\/s41598-019-49195-w.","journal-title":"Sci Rep"},{"issue":"1","key":"473_CR189","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-023-02790-4","volume":"23","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Yi J, Xiang J, Jia W, Chen A, Chen L, et al. Exploration of lung mycobiome in the patients with non-small-cell lung cancer. BMC Microbiol. 2023;23(1):81. https:\/\/doi.org\/10.1186\/s12866-023-02790-4.","journal-title":"BMC Microbiol"},{"issue":"1","key":"473_CR190","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1021-1","volume":"17","author":"G Yu","year":"2016","unstructured":"Yu G, Gail MH, Consonni D, Carugno M, Humphrys M, Pesatori AC, et al. Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features. Genome Biol. 2016;17(1):163. https:\/\/doi.org\/10.1186\/s13059-016-1021-1.","journal-title":"Genome Biol"},{"issue":"1","key":"473_CR191","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1501-6","volume":"19","author":"KL Greathouse","year":"2018","unstructured":"Greathouse KL, White JR, Vargas AJ, Bliskovsky VV, Beck JA, von Muhlinen N, et al. Interaction between the microbiome and TP53 in human lung cancer. Genome Biol. 2018;19(1):123. https:\/\/doi.org\/10.1186\/s13059-018-1501-6.","journal-title":"Genome Biol"},{"key":"473_CR192","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lungcan.2016.10.016","volume":"102","author":"SH Lee","year":"2016","unstructured":"Lee SH, Sung JY, Yong D, Chun J, Kim SY, Song JH, et al. Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung Cancer. 2016;102:89\u201395. https:\/\/doi.org\/10.1016\/j.lungcan.2016.10.016.","journal-title":"Lung Cancer"},{"issue":"4","key":"473_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101488","volume":"5","author":"Y Ma","year":"2024","unstructured":"Ma Y, Chen H, Li H, Zheng M, Zuo X, Wang W, et al. Intratumor microbiome-derived butyrate promotes lung cancer metastasis. Cell Rep Med. 2024;5(4):101488. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101488.","journal-title":"Cell Rep Med"},{"issue":"1","key":"473_CR194","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12943-022-01544-6","volume":"21","author":"EA Marshall","year":"2022","unstructured":"Marshall EA, Filho FSL, Sin DD, Lam S, Leung JM, Lam WL. Distinct bronchial microbiome precedes clinical diagnosis of lung cancer. Mol Cancer. 2022;21(1):68. https:\/\/doi.org\/10.1186\/s12943-022-01544-6.","journal-title":"Mol Cancer"},{"issue":"1","key":"473_CR195","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13073-022-01126-7","volume":"14","author":"BA Peters","year":"2022","unstructured":"Peters BA, Pass HI, Burk RD, Xue X, Goparaju C, Sollecito CC, et al. The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer. Genome Med. 2022;14(1):121. https:\/\/doi.org\/10.1186\/s13073-022-01126-7.","journal-title":"Genome Med"},{"issue":"1","key":"473_CR196","doi-asserted-by":"publisher","first-page":"11940","DOI":"10.1038\/s41598-019-48348-1","volume":"9","author":"A Smith","year":"2019","unstructured":"Smith A, Pierre JF, Makowski L, Tolley E, Lyn-Cook B, Lu L, et al. Distinct microbial communities that differ by race, stage, or breast-tumor subtype in breast tissues of non-Hispanic Black and non-Hispanic White women. Sci Rep. 2019;9(1):11940. https:\/\/doi.org\/10.1038\/s41598-019-48348-1.","journal-title":"Sci Rep"},{"issue":"9","key":"473_CR197","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41419-021-04092-x","volume":"12","author":"S Banerjee","year":"2021","unstructured":"Banerjee S, Wei Z, Tian T, Bose D, Shih NNC, Feldman MD, et al. Prognostic correlations with the microbiome of breast cancer subtypes. Cell Death Dis. 2021;12(9):831. https:\/\/doi.org\/10.1038\/s41419-021-04092-x.","journal-title":"Cell Death Dis"},{"key":"473_CR198","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fmicb.2018.00951","volume":"9","author":"S Banerjee","year":"2018","unstructured":"Banerjee S, Tian T, Wei Z, Shih N, Feldman MD, Peck KN, et al. Distinct Microbial Signatures Associated With Different Breast Cancer Types. Front Microbiol. 2018;9:951. https:\/\/doi.org\/10.3389\/fmicb.2018.00951.","journal-title":"Front Microbiol"},{"issue":"1","key":"473_CR199","doi-asserted-by":"publisher","first-page":"14116","DOI":"10.1038\/s41598-020-71102-x","volume":"10","author":"S Thyagarajan","year":"2020","unstructured":"Thyagarajan S, Zhang Y, Thapa S, Allen MS, Phillips N, Chaudhary P, et al. Comparative analysis of racial differences in breast tumor microbiome. Sci Rep. 2020;10(1):14116. https:\/\/doi.org\/10.1038\/s41598-020-71102-x.","journal-title":"Sci Rep"},{"issue":"1","key":"473_CR200","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13073-021-00874-2","volume":"13","author":"A Tzeng","year":"2021","unstructured":"Tzeng A, Sangwan N, Jia M, Liu CC, Keslar KS, Downs-Kelly E, et al. Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer. Genome Med. 2021;13(1):60. https:\/\/doi.org\/10.1186\/s13073-021-00874-2.","journal-title":"Genome Med"},{"issue":"1","key":"473_CR201","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083744","volume":"9","author":"C Xuan","year":"2014","unstructured":"Xuan C, Shamonki JM, Chung A, Dinome ML, Chung M, Sieling PA, et al. Microbial dysbiosis is associated with human breast cancer. PLoS ONE. 2014;9(1):e83744. https:\/\/doi.org\/10.1371\/journal.pone.0083744.","journal-title":"PLoS ONE"},{"key":"473_CR202","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fonc.2018.00318","volume":"8","author":"S Meng","year":"2018","unstructured":"Meng S, Chen B, Yang J, Wang J, Zhu D, Meng Q, et al. Study of Microbiomes in Aseptically Collected Samples of Human Breast Tissue Using Needle Biopsy and the Potential Role of in situ Tissue Microbiomes for Promoting Malignancy. Front Oncol. 2018;8:318. https:\/\/doi.org\/10.3389\/fonc.2018.00318.","journal-title":"Front Oncol"},{"issue":"22","key":"473_CR203","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1158\/1078-0432.Ccr-16-1786","volume":"22","author":"K Yamamura","year":"2016","unstructured":"Yamamura K, Baba Y, Nakagawa S, Mima K, Miyake K, Nakamura K, et al. Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis. Clin Cancer Res. 2016;22(22):5574\u201381. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-16-1786.","journal-title":"Clin Cancer Res"},{"key":"473_CR204","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-016-0049-x","volume":"11","author":"S Gao","year":"2016","unstructured":"Gao S, Li S, Ma Z, Liang S, Shan T, Zhang M, et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect Agent Cancer. 2016;11:3. https:\/\/doi.org\/10.1186\/s13027-016-0049-x.","journal-title":"Infect Agent Cancer"},{"issue":"7","key":"473_CR205","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00535-024-02117-8","volume":"59","author":"M Li","year":"2024","unstructured":"Li M, Shao D, Fan Z, Qin J, Xu J, Huang Q, et al. Non-invasive early detection on esophageal squamous cell carcinoma and precancerous lesions by microbial biomarkers combining epidemiological factors in China. J Gastroenterol. 2024;59(7):531\u201342. https:\/\/doi.org\/10.1007\/s00535-024-02117-8.","journal-title":"J Gastroenterol"},{"issue":"8","key":"473_CR206","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1099\/jmm.0.000754","volume":"67","author":"Y Liu","year":"2018","unstructured":"Liu Y, Lin Z, Lin Y, Chen Y, Peng XE, He F, et al. Streptococcus and Prevotella are associated with the prognosis of oesophageal squamous cell carcinoma. J Med Microbiol. 2018;67(8):1058\u201368. https:\/\/doi.org\/10.1099\/jmm.0.000754.","journal-title":"J Med Microbiol"},{"key":"473_CR207","doi-asserted-by":"publisher","unstructured":"Zhou J, Shrestha P, Qiu Z, Harman DG, Teoh WC, Al-Sohaily S, et al. Distinct Microbiota Dysbiosis in Patients with Non-Erosive Reflux Disease and Esophageal Adenocarcinoma. J Clin Med. 2020;9(7). https:\/\/doi.org\/10.3390\/jcm9072162","DOI":"10.3390\/jcm9072162"},{"key":"473_CR208","doi-asserted-by":"publisher","unstructured":"Rao WQ, Lin Z, Jiang J, Wang JW, Lin ZF, Fu R, et al. Esophageal mycobiome landscape and interkingdom interactions in esophageal squamous cell carcinoma. Gastroenterol Rep (Oxf). 2023;11:goad022. https:\/\/doi.org\/10.1093\/gastro\/goad022","DOI":"10.1093\/gastro\/goad022"},{"issue":"5","key":"473_CR209","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/1574-6976.12027","volume":"37","author":"I Yang","year":"2013","unstructured":"Yang I, Nell S, Suerbaum S. Survival in hostile territory: the microbiota of the stomach. FEMS Microbiol Rev. 2013;37(5):736\u201361. https:\/\/doi.org\/10.1111\/1574-6976.12027.","journal-title":"FEMS Microbiol Rev"},{"issue":"6","key":"473_CR210","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/gutjnl-2017-314281","volume":"67","author":"OO Coker","year":"2018","unstructured":"Coker OO, Dai Z, Nie Y, Zhao G, Cao L, Nakatsu G, et al. Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut. 2018;67(6):1024\u201332. https:\/\/doi.org\/10.1136\/gutjnl-2017-314281.","journal-title":"Gut"},{"issue":"28","key":"473_CR211","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1038\/s41388-022-02377-9","volume":"41","author":"C Liu","year":"2022","unstructured":"Liu C, Ng SK, Ding Y, Lin Y, Liu W, Wong SH, et al. Meta-analysis of mucosal microbiota reveals universal microbial signatures and dysbiosis in gastric carcinogenesis. Oncogene. 2022;41(28):3599\u2013610. https:\/\/doi.org\/10.1038\/s41388-022-02377-9.","journal-title":"Oncogene"},{"issue":"10","key":"473_CR212","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/0008-5472.Can-24-2580","volume":"85","author":"T Zhang","year":"2025","unstructured":"Zhang T, Li Y, Zhai E, Zhao R, Qian Y, Huang Z, et al. Intratumoral Fusobacterium nucleatum recruits tumor-associated neutrophils to promote gastric cancer progression and immune evasion. Cancer Res. 2025;85(10):1819\u201341. https:\/\/doi.org\/10.1158\/0008-5472.Can-24-2580.","journal-title":"Cancer Res"},{"issue":"1","key":"473_CR213","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41421-024-00746-0","volume":"10","author":"L Yuan","year":"2024","unstructured":"Yuan L, Pan L, Wang Y, Zhao J, Fang L, Zhou Y, et al. Characterization of the landscape of the intratumoral microbiota reveals that Streptococcus anginosus increases the risk of gastric cancer initiation and progression. Cell Discov. 2024;10(1):117. https:\/\/doi.org\/10.1038\/s41421-024-00746-0.","journal-title":"Cell Discov"},{"issue":"10","key":"473_CR214","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.7150\/thno.55209","volume":"11","author":"M Zhong","year":"2021","unstructured":"Zhong M, Xiong Y, Zhao J, Gao Z, Ma J, Wu Z, et al. Candida albicans disorder is associated with gastric carcinogenesis. Theranostics. 2021;11(10):4945\u201356. https:\/\/doi.org\/10.7150\/thno.55209.","journal-title":"Theranostics"},{"issue":"23","key":"473_CR215","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.1158\/0008-5472.Can-11-1349","volume":"71","author":"K Matsusaka","year":"2011","unstructured":"Matsusaka K, Kaneda A, Nagae G, Ushiku T, Kikuchi Y, Hino R, et al. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res. 2011;71(23):7187\u201397. https:\/\/doi.org\/10.1158\/0008-5472.Can-11-1349.","journal-title":"Cancer Res"},{"key":"473_CR216","doi-asserted-by":"publisher","unstructured":"Hashemi SMA, Moradi A, Hosseini SY, Razavi Nikoo H, Bamdad T, Faghih Z, et al. A New Insight Into p53-Inhibiting Genes in Epstein\u2013Barr Virus-Associated Gastric Adenocarcinoma. Iran Biomed J. 2023;27(1):34\u201345. https:\/\/doi.org\/10.52547\/ibj.3784","DOI":"10.52547\/ibj.3784"},{"issue":"5","key":"473_CR217","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s10120-021-01215-3","volume":"24","author":"M Saito","year":"2021","unstructured":"Saito M, Kono K. Landscape of EBV-positive gastric cancer. Gastric Cancer. 2021;24(5):983\u20139. https:\/\/doi.org\/10.1007\/s10120-021-01215-3.","journal-title":"Gastric Cancer"},{"issue":"2","key":"473_CR218","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.70115","volume":"18","author":"Y Wang","year":"2025","unstructured":"Wang Y, Qiu X, Chu A, Chen J, Wang L, Sun X, et al. Advances in 16S rRNA-based microbial biomarkers for gastric cancer diagnosis and prognosis. Microb Biotechnol. 2025;18(2):e70115. https:\/\/doi.org\/10.1111\/1751-7915.70115.","journal-title":"Microb Biotechnol"},{"key":"473_CR219","doi-asserted-by":"publisher","unstructured":"Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga Y, Ito M, Kurihara H, et al. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget. 2015;6(9):7209\u201320. https:\/\/doi.org\/10.18632\/oncotarget.3109","DOI":"10.18632\/oncotarget.3109"},{"issue":"1","key":"473_CR220","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1097\/mpa.0000000000000467","volume":"45","author":"S Fiorino","year":"2016","unstructured":"Fiorino S, Visani M, Acquaviva G, Fornelli A, Masetti M, Cuppini A, et al. Search for HBV and HCV genome in cancer cells of pancreatic tumors. Pancreas. 2016;45(1):e12\u20134. https:\/\/doi.org\/10.1097\/mpa.0000000000000467.","journal-title":"Pancreas"},{"issue":"1","key":"473_CR221","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s42003-021-02557-5","volume":"4","author":"W Guo","year":"2021","unstructured":"Guo W, Zhang Y, Guo S, Mei Z, Liao H, Dong H, et al. Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer. Commun Biol. 2021;4(1):1019. https:\/\/doi.org\/10.1038\/s42003-021-02557-5.","journal-title":"Commun Biol"},{"issue":"8","key":"473_CR222","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1111\/cas.16238","volume":"115","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Liang X, Zhang G, Li F, Xu J, Ma R, et al. Microbiota and metabolite alterations in pancreatic head and body\/tail cancer patients. Cancer Sci. 2024;115(8):2738\u201350. https:\/\/doi.org\/10.1111\/cas.16238.","journal-title":"Cancer Sci"},{"issue":"3","key":"473_CR223","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00535-023-02069-5","volume":"59","author":"S Abe","year":"2024","unstructured":"Abe S, Masuda A, Matsumoto T, Inoue J, Toyama H, Sakai A, et al. Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma. J Gastroenterol. 2024;59(3):250\u201362. https:\/\/doi.org\/10.1007\/s00535-023-02069-5.","journal-title":"J Gastroenterol"},{"issue":"3","key":"473_CR224","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4161\/gmic.19922","volume":"3","author":"A Kr\u00fcttgen","year":"2012","unstructured":"Kr\u00fcttgen A, Horz HP, Weber-Heynemann J, Vucur M, Trautwein C, Haase G, et al. Study on the association of Helicobacter species with viral hepatitis-induced hepatocellular carcinoma. Gut Microbes. 2012;3(3):228\u201333. https:\/\/doi.org\/10.4161\/gmic.19922.","journal-title":"Gut Microbes"},{"issue":"1","key":"473_CR225","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03938-6","volume":"21","author":"Y He","year":"2023","unstructured":"He Y, Zhang Q, Yu X, Zhang S, Guo W. Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues. J Transl Med. 2023;21(1):68. https:\/\/doi.org\/10.1186\/s12967-023-03938-6.","journal-title":"J Transl Med"},{"issue":"7","key":"473_CR226","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/hep4.1908","volume":"6","author":"D Qu","year":"2022","unstructured":"Qu D, Wang Y, Xia Q, Chang J, Jiang X, Zhang H. Intratumoral microbiome of human primary liver cancer. Hepatol Commun. 2022;6(7):1741\u201352. https:\/\/doi.org\/10.1002\/hep4.1908.","journal-title":"Hepatol Commun"},{"issue":"1","key":"473_CR227","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99973-y","volume":"15","author":"W Shen","year":"2025","unstructured":"Shen W, Li Z, Wang L, Liu Q, Zhang R, Yao Y, et al. Tumor-resident Malassezia can promote hepatocellular carcinoma development by downregulating bile acid synthesis and modulating tumor microenvironment. Sci Rep. 2025;15(1):15020. https:\/\/doi.org\/10.1038\/s41598-025-99973-y.","journal-title":"Sci Rep"},{"issue":"8","key":"473_CR228","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1158\/2159-8290.Cd-24-1259","volume":"15","author":"Y Lu","year":"2025","unstructured":"Lu Y, Xu L, Chen W, Liu W, Zhang Y, Zhou Q, et al. Intrahepatic microbial heterogeneity in multifocal hepatocellular carcinoma and its association with host genomic and transcriptomic alterations. Cancer Discov. 2025;15(8):1630\u201348. https:\/\/doi.org\/10.1158\/2159-8290.Cd-24-1259.","journal-title":"Cancer Discov"},{"issue":"1","key":"473_CR229","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07733-7","volume":"16","author":"B Pan","year":"2025","unstructured":"Pan B, Zhang X, Ye D, Yao Y, Zhang Z, Luo Y, et al. Intratumoral Brevibacillus parabrevis enhances antitumor immunity by inhibiting NK cell ferroptosis in hepatocellular carcinoma. Cell Death Dis. 2025;16(1):407. https:\/\/doi.org\/10.1038\/s41419-025-07733-7.","journal-title":"Cell Death Dis"},{"issue":"4","key":"473_CR230","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.chom.2025.03.012","volume":"33","author":"Y Lin","year":"2025","unstructured":"Lin Y, Lau HC, Liu C, Ding X, Sun Y, Rong J, et al. Multi-cohort analysis reveals colorectal cancer tumor location-associated fecal microbiota and their clinical impact. Cell Host Microbe. 2025;33(4):589-601.e3. https:\/\/doi.org\/10.1016\/j.chom.2025.03.012.","journal-title":"Cell Host Microbe"},{"issue":"7","key":"473_CR231","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1111\/jgh.15361","volume":"36","author":"S Yamamoto","year":"2021","unstructured":"Yamamoto S, Kinugasa H, Hirai M, Terasawa H, Yasutomi E, Oka S, et al. Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer. J Gastroenterol Hepatol. 2021;36(7):1869\u201376. https:\/\/doi.org\/10.1111\/jgh.15361.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"473_CR232","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41591-019-0458-7","volume":"25","author":"S Yachida","year":"2019","unstructured":"Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019;25(6):968\u201376. https:\/\/doi.org\/10.1038\/s41591-019-0458-7.","journal-title":"Nat Med"},{"issue":"8","key":"473_CR233","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gutjnl-2016-312766","volume":"66","author":"SH Wong","year":"2017","unstructured":"Wong SH, Kwong TNY, Chow TC, Luk AKC, Dai RZW, Nakatsu G, et al. Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia. Gut. 2017;66(8):1441\u20138. https:\/\/doi.org\/10.1136\/gutjnl-2016-312766.","journal-title":"Gut"},{"issue":"2","key":"473_CR234","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tim.2022.08.010","volume":"31","author":"N Wang","year":"2023","unstructured":"Wang N, Fang JY. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer. Trends Microbiol. 2023;31(2):159\u201372. https:\/\/doi.org\/10.1016\/j.tim.2022.08.010.","journal-title":"Trends Microbiol"},{"issue":"3","key":"473_CR235","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170(3):548-63.e16. https:\/\/doi.org\/10.1016\/j.cell.2017.07.008.","journal-title":"Cell"},{"issue":"5","key":"473_CR236","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.101015","volume":"6","author":"T M\u00e4klin","year":"2025","unstructured":"M\u00e4klin T, Taira A, Arredondo-Alonso S, Shao Y, Stratton MR, Lawley TD, et al. Geographical variation in the incidence of colorectal cancer and urinary tract cancer is associated with population exposure to colibactin-producing Escherichia coli. Lancet Microbe. 2025;6(5):101015. https:\/\/doi.org\/10.1016\/j.lanmic.2024.101015.","journal-title":"Lancet Microbe"},{"key":"473_CR237","doi-asserted-by":"publisher","unstructured":"Jans M, Vereecke L. Physiological drivers of pks+ E. coli in colorectal cancer. Trends Microbiol. 2025;33(9):1003\u201317. https:\/\/doi.org\/10.1016\/j.tim.2025.04.010","DOI":"10.1016\/j.tim.2025.04.010"},{"issue":"4","key":"473_CR238","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41579-023-00973-4","volume":"22","author":"MT White","year":"2024","unstructured":"White MT, Sears CL. The microbial landscape of colorectal cancer. Nat Rev Microbiol. 2024;22(4):240\u201354. https:\/\/doi.org\/10.1038\/s41579-023-00973-4.","journal-title":"Nat Rev Microbiol"},{"issue":"6375","key":"473_CR239","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.aah3648","volume":"359","author":"CM Dejea","year":"2018","unstructured":"Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018;359(6375):592\u20137. https:\/\/doi.org\/10.1126\/science.aah3648.","journal-title":"Science"},{"key":"473_CR240","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2020.05.004","volume":"70","author":"H Si","year":"2021","unstructured":"Si H, Yang Q, Hu H, Ding C, Wang H, Lin X. Colorectal cancer occurrence and treatment based on changes in intestinal flora. Semin Cancer Biol. 2021;70:3\u201310. https:\/\/doi.org\/10.1016\/j.semcancer.2020.05.004.","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"473_CR241","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41591-019-0405-7","volume":"25","author":"AM Thomas","year":"2019","unstructured":"Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med. 2019;25(4):667\u201378. https:\/\/doi.org\/10.1038\/s41591-019-0405-7.","journal-title":"Nat Med"},{"issue":"4","key":"473_CR242","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","volume":"25","author":"J Wirbel","year":"2019","unstructured":"Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25(4):679\u201389. https:\/\/doi.org\/10.1038\/s41591-019-0406-6.","journal-title":"Nat Med"},{"issue":"8","key":"473_CR243","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/s1473-3099(13)70107-5","volume":"13","author":"A Boleij","year":"2013","unstructured":"Boleij A, Tjalsma H. The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease. Lancet Infect Dis. 2013;13(8):719\u201324. https:\/\/doi.org\/10.1016\/s1473-3099(13)70107-5.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"473_CR244","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/gutjnl-2018-317178","volume":"68","author":"OO Coker","year":"2019","unstructured":"Coker OO, Nakatsu G, Dai RZ, Wu WKK, Wong SH, Ng SC, et al. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer. Gut. 2019;68(4):654\u201362. https:\/\/doi.org\/10.1136\/gutjnl-2018-317178.","journal-title":"Gut"},{"issue":"30","key":"473_CR245","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.3748\/wjg.v18.i30.4051","volume":"18","author":"TH Chen","year":"2012","unstructured":"Chen TH, Huang CC, Yeh KT, Chang SH, Chang SW, Sung WW, et al. Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer. World J Gastroenterol. 2012;18(30):4051\u20138. https:\/\/doi.org\/10.3748\/wjg.v18.i30.4051.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"473_CR246","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s40001-022-00756-2","volume":"27","author":"CY Fang","year":"2022","unstructured":"Fang CY, Chen SY, Hsiao BX, Huang HY, Chen YJ, Tung CL. Unusually high incidence of polyomavirus JC infection in the higher grade of colorectal cancer tissues in Taiwan. Eur J Med Res. 2022;27(1):127. https:\/\/doi.org\/10.1186\/s40001-022-00756-2.","journal-title":"Eur J Med Res"},{"issue":"1","key":"473_CR247","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1479-7364-7-23","volume":"7","author":"D Salyakina","year":"2013","unstructured":"Salyakina D, Tsinoremas NF. Viral expression associated with gastrointestinal adenocarcinomas in TCGA high-throughput sequencing data. Hum Genomics. 2013;7(1):23. https:\/\/doi.org\/10.1186\/1479-7364-7-23.","journal-title":"Hum Genomics"},{"issue":"2","key":"473_CR248","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1053\/j.gastro.2018.04.018","volume":"155","author":"G Nakatsu","year":"2018","unstructured":"Nakatsu G, Zhou H, Wu WKK, Wong SH, Coker OO, Dai Z, et al. Alterations in enteric virome are associated with colorectal cancer and survival outcomes. Gastroenterology. 2018;155(2):529-41.e5. https:\/\/doi.org\/10.1053\/j.gastro.2018.04.018.","journal-title":"Gastroenterology"},{"key":"473_CR249","doi-asserted-by":"publisher","unstructured":"Kneis B, Wirtz S, Weber K, Denz A, Gittler M, Geppert C, et al. Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association. Int J Mol Sci. 2023;24(4). https:\/\/doi.org\/10.3390\/ijms24043265","DOI":"10.3390\/ijms24043265"},{"issue":"1","key":"473_CR250","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11237-6","volume":"7","author":"RV Purcell","year":"2017","unstructured":"Purcell RV, Visnovska M, Biggs PJ, Schmeier S, Frizelle FA. Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer. Sci Rep. 2017;7(1):11590. https:\/\/doi.org\/10.1038\/s41598-017-11237-6.","journal-title":"Sci Rep"},{"issue":"7","key":"473_CR251","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1053\/j.gastro.2021.02.020","volume":"160","author":"W Liu","year":"2021","unstructured":"Liu W, Zhang X, Xu H, Li S, Lau HC, Chen Q, et al. Microbial community heterogeneity within colorectal neoplasia and its correlation with colorectal carcinogenesis. Gastroenterology. 2021;160(7):2395\u2013408. https:\/\/doi.org\/10.1053\/j.gastro.2021.02.020.","journal-title":"Gastroenterology"},{"key":"473_CR252","doi-asserted-by":"publisher","unstructured":"Banerjee S, Tian T, Wei Z, Shih N, Feldman MD, Alwine JC, et al. The ovarian cancer oncobiome. Oncotarget. 2017;8(22):36225\u201345. https:\/\/doi.org\/10.18632\/oncotarget.16717","DOI":"10.18632\/oncotarget.16717"},{"issue":"9","key":"473_CR253","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s10096-012-1570-5","volume":"31","author":"S Shanmughapriya","year":"2012","unstructured":"Shanmughapriya S, Senthilkumar G, Vinodhini K, Das BC, Vasanthi N, Natarajaseenivasan K. Viral and bacterial aetiologies of epithelial ovarian cancer. Eur J Clin Microbiol Infect Dis. 2012;31(9):2311\u20137. https:\/\/doi.org\/10.1007\/s10096-012-1570-5.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"473_CR254","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s13167-022-00286-1","volume":"13","author":"X Qin","year":"2022","unstructured":"Qin X, Zhou J, Wang Z, Feng C, Fan J, Huang J, et al. Metagenomic analysis of the microbiome of the upper reproductive tract: combating ovarian cancer through predictive, preventive, and personalized medicine. EPMA J. 2022;13(3):487\u201398. https:\/\/doi.org\/10.1007\/s13167-022-00286-1.","journal-title":"EPMA J"},{"issue":"2","key":"473_CR255","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03549-22","volume":"11","author":"D Sheng","year":"2023","unstructured":"Sheng D, Yue K, Li H, Zhao L, Zhao G, Jin C, et al. The Interaction between Intratumoral Microbiome and Immunity Is Related to the Prognosis of Ovarian Cancer. Microbiol Spectr. 2023;11(2):e0354922. https:\/\/doi.org\/10.1128\/spectrum.03549-22.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"473_CR256","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-024-01464-7","volume":"17","author":"H Qin","year":"2024","unstructured":"Qin H, Liu J, Qu Y, Li YY, Xu YL, Yan YF. The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma. J Ovarian Res. 2024;17(1):140. https:\/\/doi.org\/10.1186\/s13048-024-01464-7.","journal-title":"J Ovarian Res"},{"key":"473_CR257","doi-asserted-by":"publisher","unstructured":"Gon\u00e7alves MFM, Pina-Vaz T, Fernandes \u00c2 R, Miranda IM, Silva CM, Rodrigues AG, et al. Microbiota of Urine, Glans and Prostate Biopsies in Patients with Prostate Cancer Reveals a Dysbiosis in the Genitourinary System. Cancers (Basel). 2023;15(5). https:\/\/doi.org\/10.3390\/cancers15051423","DOI":"10.3390\/cancers15051423"},{"issue":"6","key":"473_CR258","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/carcin\/bgz008","volume":"40","author":"S Banerjee","year":"2019","unstructured":"Banerjee S, Alwine JC, Wei Z, Tian T, Shih N, Sperling C, et al. Microbiome signatures in prostate cancer. Carcinogenesis. 2019;40(6):749\u201364. https:\/\/doi.org\/10.1093\/carcin\/bgz008.","journal-title":"Carcinogenesis"},{"issue":"1","key":"473_CR259","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0368-y","volume":"8","author":"MR Walther-Ant\u00f3nio","year":"2016","unstructured":"Walther-Ant\u00f3nio MR, Chen J, Multinu F, Hokenstad A, Distad TJ, Cheek EH, et al. Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Med. 2016;8(1):122. https:\/\/doi.org\/10.1186\/s13073-016-0368-y.","journal-title":"Genome Med"},{"issue":"1","key":"473_CR260","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01821-0","volume":"12","author":"A Semertzidou","year":"2024","unstructured":"Semertzidou A, Whelan E, Smith A, Ng S, Roberts L, Brosens JJ, et al. Microbial signatures and continuum in endometrial cancer and benign patients. Microbiome. 2024;12(1):118. https:\/\/doi.org\/10.1186\/s40168-024-01821-0.","journal-title":"Microbiome"},{"issue":"6","key":"473_CR261","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27879","volume":"10","author":"J Liu","year":"2024","unstructured":"Liu J, Qu Y, Li YY, Xu YL, Yan YF, Qin H. Exploring prognostic microbiota markers in patients with endometrial carcinoma: intratumoral insights. Heliyon. 2024;10(6):e27879. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27879.","journal-title":"Heliyon"},{"issue":"1","key":"473_CR262","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62531-z","volume":"14","author":"X Li","year":"2024","unstructured":"Li X, Xiang F, Liu T, Chen Z, Zhang M, Li J, et al. Leveraging existing 16S rRNA gene surveys to decipher microbial signatures and dysbiosis in cervical carcinogenesis. Sci Rep. 2024;14(1):11532. https:\/\/doi.org\/10.1038\/s41598-024-62531-z.","journal-title":"Sci Rep"},{"key":"473_CR263","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2147\/cmar.S165228","volume":"10","author":"X Yang","year":"2018","unstructured":"Yang X, Da M, Zhang W, Qi Q, Zhang C, Han S. Role of Lactobacillus in cervical cancer. Cancer Manag Res. 2018;10:1219\u201329. https:\/\/doi.org\/10.2147\/cmar.S165228.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"473_CR264","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-020-0347-4","volume":"19","author":"N Kalia","year":"2020","unstructured":"Kalia N, Singh J, Kaur M. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review. Ann Clin Microbiol Antimicrob. 2020;19(1):5. https:\/\/doi.org\/10.1186\/s12941-020-0347-4.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"5","key":"473_CR265","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00151-22","volume":"10","author":"H Liu","year":"2022","unstructured":"Liu H, Liang H, Li D, Wang M, Li Y. Association of cervical dysbacteriosis, HPV oncogene expression, and cervical lesion progression. Microbiol Spectr. 2022;10(5):e0015122. https:\/\/doi.org\/10.1128\/spectrum.00151-22.","journal-title":"Microbiol Spectr"},{"key":"473_CR266","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1440017","volume":"14","author":"X Zhou","year":"2024","unstructured":"Zhou X, Chen L, Lin W, Zheng W, Zhang H, Zhou F. Diagnostic and prognostic potential of the intra-tumoral microbiota profile in HPV-independent endocervical adenocarcinoma. Front Cell Infect Microbiol. 2024;14:1440017. https:\/\/doi.org\/10.3389\/fcimb.2024.1440017.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"473_CR267","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-025-03599-1","volume":"25","author":"Q Wen","year":"2025","unstructured":"Wen Q, Wang S, Min Y, Liu X, Fang J, Lang J, et al. Associations of the gut, cervical, and vaginal microbiota with cervical cancer: a systematic review and meta-analysis. BMC Womens Health. 2025;25(1):65. https:\/\/doi.org\/10.1186\/s12905-025-03599-1.","journal-title":"BMC Womens Health"},{"key":"473_CR268","doi-asserted-by":"publisher","unstructured":"G\u0142owienka-Stodolak M, Bagi\u0144ska-Drabiuk K, Szubert S, Hennig EE, Horala A, D\u0105browska M, et al. Human Papillomavirus Infections and the Role Played by Cervical and Cervico-Vaginal Microbiota-Evidence from Next-Generation Sequencing Studies. Cancers (Basel). 2024;16(2). https:\/\/doi.org\/10.3390\/cancers16020399","DOI":"10.3390\/cancers16020399"},{"issue":"1","key":"473_CR269","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67443-2","volume":"10","author":"B Mansour","year":"2020","unstructured":"Mansour B, Mony\u00f3k \u00c1, Makra N, Gajd\u00e1cs M, Vadnay I, Ligeti B, et al. Bladder cancer-related microbiota: examining differences in urine and tissue samples. Sci Rep. 2020;10(1):11042. https:\/\/doi.org\/10.1038\/s41598-020-67443-2.","journal-title":"Sci Rep"},{"key":"473_CR270","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1182322","volume":"13","author":"JX Sun","year":"2023","unstructured":"Sun JX, Xia QD, Zhong XY, Liu Z, Wang SG. The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M. Front Cell Infect Microbiol. 2023;13:1182322. https:\/\/doi.org\/10.3389\/fcimb.2023.1182322.","journal-title":"Front Cell Infect Microbiol"},{"key":"473_CR271","doi-asserted-by":"publisher","unstructured":"Knorr J, Lone Z, Werneburg G, Adler A, Agudelo J, Suryavanshi M, et al. An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer. Urol Oncol. 2024;42(9):291.e1-.e11. https:\/\/doi.org\/10.1016\/j.urolonc.2024.04.011","DOI":"10.1016\/j.urolonc.2024.04.011"},{"issue":"1","key":"473_CR272","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13817-6","volume":"25","author":"Z Sheng","year":"2025","unstructured":"Sheng Z, Xu J, Wang M, Xu X, Zhu J, Zeng S, et al. The role of urinary microbiota in primary and recurrent bladder cancer: insights from a propensity score matching study. BMC Cancer. 2025;25(1):468. https:\/\/doi.org\/10.1186\/s12885-025-13817-6.","journal-title":"BMC Cancer"},{"issue":"1","key":"473_CR273","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72918-7","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Lin H, Liang L, Jin S, Lv J, Zhou Y, et al. Intratumoral microbiota as a novel prognostic indicator in bladder cancer. Sci Rep. 2024;14(1):22198. https:\/\/doi.org\/10.1038\/s41598-024-72918-7.","journal-title":"Sci Rep"},{"issue":"3-4","key":"473_CR274","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000504029","volume":"104","author":"S Heidler","year":"2020","unstructured":"Heidler S, Lusuardi L, Madersbacher S, Freibauer C. The microbiome in benign renal tissue and in renal cell carcinoma. Urol Int. 2020;104(3\u20134):247\u201352. https:\/\/doi.org\/10.1159\/000504029.","journal-title":"Urol Int"},{"issue":"2","key":"473_CR275","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00432-020-03462-w","volume":"147","author":"J Wang","year":"2021","unstructured":"Wang J, Li X, Wu X, Wang Z, Zhang C, Cao G, et al. Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing. J Cancer Res Clin Oncol. 2021;147(2):481\u201391. https:\/\/doi.org\/10.1007\/s00432-020-03462-w.","journal-title":"J Cancer Res Clin Oncol"},{"key":"473_CR276","doi-asserted-by":"publisher","unstructured":"Kovaleva OV, Podlesnaya P, Sorokin M, Mochalnikova V, Kataev V, Khlopko YA, et al. Macrophage Phenotype in Combination with Tumor Microbiome Composition Predicts RCC Patients' Survival: A Pilot Study. Biomedicines. 2022;10(7). https:\/\/doi.org\/10.3390\/biomedicines10071516","DOI":"10.3390\/biomedicines10071516"},{"issue":"1","key":"473_CR277","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00345-024-05403-5","volume":"43","author":"J Zhang","year":"2025","unstructured":"Zhang J, Lou K, Chi J, Wu J, Fan X, Cui Y. Research progress on intratumoral microorganisms in renal cancer. World J Urol. 2025;43(1):72. https:\/\/doi.org\/10.1007\/s00345-024-05403-5.","journal-title":"World J Urol"},{"issue":"19","key":"473_CR278","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38310","volume":"10","author":"H Xu","year":"2024","unstructured":"Xu H, Leng J, Liu F, Chen T, Qu J, Yang Y, et al. Tumor microbiota of renal cell carcinoma affects clinical prognosis by influencing the tumor immune microenvironment. Heliyon. 2024;10(19):e38310. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38310.","journal-title":"Heliyon"},{"key":"473_CR279","doi-asserted-by":"publisher","unstructured":"Kryst P, Poletajew S, Wycza\u0142kowska-Tomasik A, Gonczar S, Wysocki M, Kapu\u015bci\u0144ska R, et al. Epstein-Barr Virus and Human Adenovirus Viremia in Renal Tumors Is Associated with Histological Features of Malignancy. J Clin Med. 2020;9(10). https:\/\/doi.org\/10.3390\/jcm9103195","DOI":"10.3390\/jcm9103195"},{"issue":"7","key":"473_CR280","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/jmv.23945","volume":"86","author":"A Farhadi","year":"2014","unstructured":"Farhadi A, Behzad-Behbahani A, Geramizadeh B, Sekawi Z, Rahsaz M, Sharifzadeh S. High-risk human papillomavirus infection in different histological subtypes of renal cell carcinoma. J Med Virol. 2014;86(7):1134\u201344. https:\/\/doi.org\/10.1002\/jmv.23945.","journal-title":"J Med Virol"},{"key":"473_CR281","doi-asserted-by":"publisher","unstructured":"Huang R, Su X, Wang J, Sun Q, Kang D, Li L, et al. Characteristics of cancer mycobiome in patients with acral melanoma. J Immunother Cancer. 2025;13(7). https:\/\/doi.org\/10.1136\/jitc-2024-011097","DOI":"10.1136\/jitc-2024-011097"},{"issue":"3","key":"473_CR282","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12223-018-00670-3","volume":"64","author":"J Mr\u00e1zek","year":"2019","unstructured":"Mr\u00e1zek J, Mekadim C, Ku\u010derov\u00e1 P, \u0160vejstil R, Salmonov\u00e1 H, Vlas\u00e1kov\u00e1 J, et al. Melanoma-related changes in skin microbiome. Folia Microbiol (Praha). 2019;64(3):435\u201342. https:\/\/doi.org\/10.1007\/s12223-018-00670-3.","journal-title":"Folia Microbiol (Praha)"},{"key":"473_CR283","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1091379","volume":"13","author":"JI Bromfield","year":"2023","unstructured":"Bromfield JI, Hugenholtz P, Frazer IH, Khosrotehrani K, Chandra J. Targeting Staphylococcus aureus dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: outlook for future therapies? Front Oncol. 2023;13:1091379. https:\/\/doi.org\/10.3389\/fonc.2023.1091379.","journal-title":"Front Oncol"},{"key":"473_CR284","doi-asserted-by":"publisher","unstructured":"Wood DLA, Lachner N, Tan JM, Tang S, Angel N, Laino A, et al. A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes. mBio. 2018;9(5). https:\/\/doi.org\/10.1128\/mBio.01432-18","DOI":"10.1128\/mBio.01432-18"},{"issue":"7","key":"473_CR285","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ijc.28176","volume":"133","author":"SF Farzan","year":"2013","unstructured":"Farzan SF, Waterboer T, Gui J, Nelson HH, Li Z, Michael KM, et al. Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study. Int J Cancer. 2013;133(7):1713\u201320. https:\/\/doi.org\/10.1002\/ijc.28176.","journal-title":"Int J Cancer"},{"issue":"7","key":"473_CR286","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002125","volume":"7","author":"D Viarisio","year":"2011","unstructured":"Viarisio D, Mueller-Decker K, Kloz U, Aengeneyndt B, Kopp-Schneider A, Gr\u00f6ne HJ, et al. E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog. 2011;7(7):e1002125. https:\/\/doi.org\/10.1371\/journal.ppat.1002125.","journal-title":"PLoS Pathog"},{"issue":"4","key":"473_CR287","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00262-025-03972-x","volume":"74","author":"Z Yijia","year":"2025","unstructured":"Yijia Z, Li X, Ma L, Wang S, Du H, Wu Y, et al. Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma. Cancer Immunol Immunother. 2025;74(4):131. https:\/\/doi.org\/10.1007\/s00262-025-03972-x.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"473_CR288","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/2050640615612934","volume":"4","author":"J Moleiro","year":"2016","unstructured":"Moleiro J, Ferreira S, Lage P, Dias Pereira A. Gastric MALT lymphoma: analysis of a series of consecutive patients over 20 years. United Eur Gastroenterol J. 2016;4(3):395\u2013402. https:\/\/doi.org\/10.1177\/2050640615612934.","journal-title":"United Eur Gastroenterol J"},{"issue":"5","key":"473_CR289","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.semcancer.2011.09.010","volume":"21","author":"KE Smedby","year":"2011","unstructured":"Smedby KE, Hjalgrim H. Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes. Semin Cancer Biol. 2011;21(5):293\u20138. https:\/\/doi.org\/10.1016\/j.semcancer.2011.09.010.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"473_CR290","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1309\/ajcpxmdrt1sy6kiv","volume":"135","author":"A Aigelsreiter","year":"2011","unstructured":"Aigelsreiter A, Gerlza T, Deutsch AJ, Leitner E, Beham-Schmid C, Beham A, et al. Chlamydia psittaci infection in nongastrointestinal extranodal MALT lymphomas and their precursor lesions. Am J Clin Pathol. 2011;135(1):70\u20135. https:\/\/doi.org\/10.1309\/ajcpxmdrt1sy6kiv.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"473_CR291","doi-asserted-by":"publisher","first-page":"580","DOI":"10.4143\/crt.2024.689","volume":"57","author":"JH Kim","year":"2025","unstructured":"Kim JH, Kim JS, Choi N, Koh J, Jeon YK, Chang JH, et al. Higher microbial abundance and diversity in bronchus-associated lymphoid tissue lymphomas than in non-cancerous lung tissues. Cancer Res Treat. 2025;57(2):580\u20139. https:\/\/doi.org\/10.4143\/crt.2024.689.","journal-title":"Cancer Res Treat"},{"issue":"12","key":"473_CR292","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"LS Young","year":"2016","unstructured":"Young LS, Yap LF, Murray PG. Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer. 2016;16(12):789\u2013802. https:\/\/doi.org\/10.1038\/nrc.2016.92.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"473_CR293","doi-asserted-by":"publisher","DOI":"10.1002\/jbio.202100351","volume":"15","author":"J Zhao","year":"2022","unstructured":"Zhao J, He D, Lai HM, Xu Y, Luo Y, Li T, et al. Comprehensive histological imaging of native microbiota in human glioma. J Biophotonics. 2022;15(4):e202100351. https:\/\/doi.org\/10.1002\/jbio.202100351.","journal-title":"J Biophotonics"},{"key":"473_CR294","doi-asserted-by":"publisher","unstructured":"Escapa IF, Chen T, Huang Y, Gajare P, Dewhirst FE, Lemon KP. New Insights into Human Nostril Microbiome from the Expanded Human Oral Microbiome Database (eHOMD): a Resource for the Microbiome of the Human Aerodigestive Tract. mSystems. 2018;3(6). https:\/\/doi.org\/10.1128\/mSystems.00187-18","DOI":"10.1128\/mSystems.00187-18"},{"issue":"2","key":"473_CR295","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41579-023-00963-6","volume":"22","author":"JL Baker","year":"2024","unstructured":"Baker JL, Mark Welch JL, Kauffman KM, McLean JS, He X. The oral microbiome: diversity, biogeography and human health. Nat Rev Microbiol. 2024;22(2):89\u2013104. https:\/\/doi.org\/10.1038\/s41579-023-00963-6.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"473_CR296","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/0022034514521814","volume":"93","author":"BP Krom","year":"2014","unstructured":"Krom BP, Kidwai S, Ten Cate JM. Candida and other fungal species: forgotten players of healthy oral microbiota. J Dent Res. 2014;93(5):445\u201351. https:\/\/doi.org\/10.1177\/0022034514521814.","journal-title":"J Dent Res"},{"issue":"2","key":"473_CR297","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/0022034520956975","volume":"100","author":"PI Diaz","year":"2021","unstructured":"Diaz PI, Dongari-Bagtzoglou A. Critically appraising the significance of the oral mycobiome. J Dent Res. 2021;100(2):133\u201340. https:\/\/doi.org\/10.1177\/0022034520956975.","journal-title":"J Dent Res"},{"key":"473_CR298","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2023.105631","volume":"147","author":"JO Santos","year":"2023","unstructured":"Santos JO, Rold\u00e1n WH. Entamoeba gingivalis and Trichomonas tenax: protozoa parasites living in the mouth. Arch Oral Biol. 2023;147:105631. https:\/\/doi.org\/10.1016\/j.archoralbio.2023.105631.","journal-title":"Arch Oral Biol"},{"issue":"4","key":"473_CR299","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121565","volume":"10","author":"HT Huynh","year":"2015","unstructured":"Huynh HT, Pignoly M, Nkamga VD, Drancourt M, Aboudharam G. The repertoire of archaea cultivated from severe periodontitis. PLoS ONE. 2015;10(4):e0121565. https:\/\/doi.org\/10.1371\/journal.pone.0121565.","journal-title":"PLoS ONE"},{"issue":"5","key":"473_CR300","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/ismej.2011.169","volume":"6","author":"DT Pride","year":"2012","unstructured":"Pride DT, Salzman J, Haynes M, Rohwer F, Davis-Long C, White RA 3rd, et al. Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome. Isme j. 2012;6(5):915\u201326. https:\/\/doi.org\/10.1038\/ismej.2011.169.","journal-title":"Isme j"},{"issue":"5","key":"473_CR301","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/1878-0261.13517","volume":"18","author":"Z Lan","year":"2024","unstructured":"Lan Z, Zou KL, Cui H, Zhao YY, Yu GT. Porphyromonas gingivalis suppresses oral squamous cell carcinoma progression by inhibiting MUC1 expression and remodeling the tumor microenvironment. Mol Oncol. 2024;18(5):1174\u201388. https:\/\/doi.org\/10.1002\/1878-0261.13517.","journal-title":"Mol Oncol"},{"key":"473_CR302","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216814","volume":"588","author":"X Wang","year":"2024","unstructured":"Wang X, Xu T, Wu S, Li L, Cai X, Chen F, et al. Candida albicans-myeloid cells-T lymphocytes axis in the tumor microenvironment of oral tumor-bearing mice. Cancer Lett. 2024;588:216814. https:\/\/doi.org\/10.1016\/j.canlet.2024.216814.","journal-title":"Cancer Lett"},{"issue":"1","key":"473_CR303","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41467-024-55660-6","volume":"16","author":"F Faraji","year":"2025","unstructured":"Faraji F, Ramirez SI, Clubb LM, Sato K, Burghi V, Hoang TS, et al. YAP-driven malignant reprogramming of oral epithelial stem cells at single cell resolution. Nat Commun. 2025;16(1):498. https:\/\/doi.org\/10.1038\/s41467-024-55660-6.","journal-title":"Nat Commun"},{"issue":"14","key":"473_CR304","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1007\/s00018-020-03452-8","volume":"77","author":"M Sommariva","year":"2020","unstructured":"Sommariva M, Le Noci V, Bianchi F, Camelliti S, Balsari A, Tagliabue E, et al. The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy. Cell Mol Life Sci. 2020;77(14):2739\u201349. https:\/\/doi.org\/10.1007\/s00018-020-03452-8.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"473_CR305","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"473_CR306","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1128\/aem.00242-14","volume":"80","author":"C Urbaniak","year":"2014","unstructured":"Urbaniak C, Cummins J, Brackstone M, Macklaim JM, Gloor GB, Baban CK, et al. Microbiota of human breast tissue. Appl Environ Microbiol. 2014;80(10):3007\u201314. https:\/\/doi.org\/10.1128\/aem.00242-14.","journal-title":"Appl Environ Microbiol"},{"issue":"16","key":"473_CR307","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1128\/aem.01235-16","volume":"82","author":"C Urbaniak","year":"2016","unstructured":"Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G. The microbiota of breast tissue and its association with breast cancer. Appl Environ Microbiol. 2016;82(16):5039\u201348. https:\/\/doi.org\/10.1128\/aem.01235-16.","journal-title":"Appl Environ Microbiol"},{"issue":"S3","key":"473_CR308","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7314\/apjcp.2016.17.s3.279","volume":"17","author":"HR Yazdi","year":"2016","unstructured":"Yazdi HR, Movafagh A, Fallah F, Alizadeh Shargh S, Mansouri N, Heidary Pour A, et al. Evaluation of Methylobacterium radiotolerance and Sphyngomonas yanoikoaie in Sentinel Lymph Nodes of Breast Cancer Cases. Asian Pac J Cancer Prev. 2016;17(S3):279\u201385. https:\/\/doi.org\/10.7314\/apjcp.2016.17.s3.279.","journal-title":"Asian Pac J Cancer Prev"},{"key":"473_CR309","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01603","volume":"9","author":"L Dong","year":"2018","unstructured":"Dong L, Yin J, Zhao J, Ma SR, Wang HR, Wang M, et al. Microbial similarity and preference for specific sites in healthy oral cavity and esophagus. Front Microbiol. 2018;9:1603. https:\/\/doi.org\/10.3389\/fmicb.2018.01603.","journal-title":"Front Microbiol"},{"key":"473_CR310","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-130","volume":"13","author":"N Liu","year":"2013","unstructured":"Liu N, Ando T, Ishiguro K, Maeda O, Watanabe O, Funasaka K, et al. Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett\u2019s esophagus. BMC Infect Dis. 2013;13:130. https:\/\/doi.org\/10.1186\/1471-2334-13-130.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"473_CR311","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2505118","volume":"17","author":"Y Baba","year":"2025","unstructured":"Baba Y, Tajima K, Yoshimura K. Intestinal and esophageal microbiota in esophageal cancer development and treatment. Gut Microbes. 2025;17(1):2505118. https:\/\/doi.org\/10.1080\/19490976.2025.2505118.","journal-title":"Gut Microbes"},{"key":"473_CR312","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.774330","volume":"11","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Wang J, Shen Z, Zhang Z, Wang S. Characterization of esophageal microbiota in patients with esophagitis and esophageal squamous cell carcinoma. Front Cell Infect Microbiol. 2021;11:774330. https:\/\/doi.org\/10.3389\/fcimb.2021.774330.","journal-title":"Front Cell Infect Microbiol"},{"key":"473_CR313","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ebiom.2018.12.034","volume":"40","author":"X Liu","year":"2019","unstructured":"Liu X, Shao L, Liu X, Ji F, Mei Y, Cheng Y, et al. Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer. EBioMedicine. 2019;40:336\u201348. https:\/\/doi.org\/10.1016\/j.ebiom.2018.12.034.","journal-title":"EBioMedicine"},{"key":"473_CR314","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1138928","volume":"14","author":"X Peng","year":"2023","unstructured":"Peng X, Yao S, Huang J, Zhao Y, Chen H, Chen L, et al. Alterations in bacterial community dynamics from noncancerous to gastric cancer. Front Microbiol. 2023;14:1138928. https:\/\/doi.org\/10.3389\/fmicb.2023.1138928.","journal-title":"Front Microbiol"},{"issue":"1","key":"473_CR315","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2369336","volume":"16","author":"G Wang","year":"2024","unstructured":"Wang G, Wang H, Ji X, Wang T, Zhang Y, Jiang W, et al. Intratumoral microbiome is associated with gastric cancer prognosis and therapy efficacy. Gut Microbes. 2024;16(1):2369336. https:\/\/doi.org\/10.1080\/19490976.2024.2369336.","journal-title":"Gut Microbes"},{"key":"473_CR316","doi-asserted-by":"publisher","unstructured":"Gunathilake M, Lee JH, Choi IJ, Kim YI, Kim JS. Effect of the Interaction between Dietary Patterns and the Gastric Microbiome on the Risk of Gastric Cancer. Nutrients. 2021;13(8). https:\/\/doi.org\/10.3390\/nu13082692","DOI":"10.3390\/nu13082692"},{"issue":"1","key":"473_CR317","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41575-019-0242-7","volume":"17","author":"RM Thomas","year":"2020","unstructured":"Thomas RM, Jobin C. Microbiota in pancreatic health and disease: the next frontier in microbiome research. Nat Rev Gastroenterol Hepatol. 2020;17(1):53\u201364. https:\/\/doi.org\/10.1038\/s41575-019-0242-7.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"473_CR318","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R, et al. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther. 2025;10(1):35. https:\/\/doi.org\/10.1038\/s41392-024-02075-w.","journal-title":"Signal Transduct Target Ther"},{"key":"473_CR319","doi-asserted-by":"publisher","unstructured":"Liu B, Zhou Z, Jin Y, Lu J, Feng D, Peng R, et al. Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma. J Immunother Cancer. 2022;10(1). https:\/\/doi.org\/10.1136\/jitc-2021-003069","DOI":"10.1136\/jitc-2021-003069"},{"issue":"5","key":"473_CR320","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00983-22","volume":"10","author":"JH Huang","year":"2022","unstructured":"Huang JH, Wang J, Chai XQ, Li ZC, Jiang YH, Li J, et al. The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma. Microbiol Spectr. 2022;10(5):e0098322. https:\/\/doi.org\/10.1128\/spectrum.00983-22.","journal-title":"Microbiol Spectr"},{"issue":"Pt 3","key":"473_CR321","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.semcancer.2022.01.004","volume":"86","author":"TM Karpi\u0144ski","year":"2022","unstructured":"Karpi\u0144ski TM, O\u017carowski M, Stasiewicz M. Carcinogenic microbiota and its role in colorectal cancer development. Semin Cancer Biol. 2022;86(Pt 3):420\u201330. https:\/\/doi.org\/10.1016\/j.semcancer.2022.01.004.","journal-title":"Semin Cancer Biol"},{"issue":"7415","key":"473_CR322","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","volume":"489","author":"CA Lozupone","year":"2012","unstructured":"Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220\u201330. https:\/\/doi.org\/10.1038\/nature11550.","journal-title":"Nature"},{"issue":"3","key":"473_CR323","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/21505594.2016.1247140","volume":"8","author":"HE Hallen-Adams","year":"2017","unstructured":"Hallen-Adams HE, Suhr MJ. Fungi in the healthy human gastrointestinal tract. Virulence. 2017;8(3):352\u20138. https:\/\/doi.org\/10.1080\/21505594.2016.1247140.","journal-title":"Virulence"},{"key":"473_CR324","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082668","author":"M Matija\u0161i\u0107","year":"2020","unstructured":"Matija\u0161i\u0107 M, Me\u0161trovi\u0107 T, Paljetak H, Peri\u0107 M, Bare\u0161i\u0107 A, Verbanac D. Gut microbiota beyond bacteria-mycobiome, virome, archaeome, and eukaryotic parasites in IBD. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21082668.","journal-title":"Int J Mol Sci"},{"key":"473_CR325","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216039","volume":"555","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Hou X, Bian Z, Jia W, Zhao L. Gut microbiota and colorectal cancer metastasis. Cancer Lett. 2023;555:216039. https:\/\/doi.org\/10.1016\/j.canlet.2022.216039.","journal-title":"Cancer Lett"},{"issue":"1","key":"473_CR326","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s41467-022-28913-5","volume":"13","author":"S Chen","year":"2022","unstructured":"Chen S, Zhang L, Li M, Zhang Y, Sun M, Wang L, et al. Fusobacterium nucleatum reduces METTL3-mediated m(6)A modification and contributes to colorectal cancer metastasis. Nat Commun. 2022;13(1):1248. https:\/\/doi.org\/10.1038\/s41467-022-28913-5.","journal-title":"Nat Commun"},{"issue":"11","key":"473_CR327","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1136\/gutjnl-2023-330291","volume":"72","author":"X Kang","year":"2023","unstructured":"Kang X, Liu C, Ding Y, Ni Y, Ji F, Lau HCH, et al. Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8(+) T cells. Gut. 2023;72(11):2112\u201322. https:\/\/doi.org\/10.1136\/gutjnl-2023-330291.","journal-title":"Gut"},{"issue":"1","key":"473_CR328","doi-asserted-by":"publisher","first-page":"2508949","DOI":"10.1080\/19490976.2025.2508949","volume":"17","author":"S Zhou","year":"2025","unstructured":"Zhou S, Wang K, Huang J, Xu Z, Yuan Q, Liu L, et al. Indole-3-lactic acid suppresses colorectal cancer via metabolic reprogramming. Gut Microbes. 2025;17(1):2508949. https:\/\/doi.org\/10.1080\/19490976.2025.2508949.","journal-title":"Gut Microbes"},{"key":"473_CR329","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/1743-422x-10-343","volume":"10","author":"OA Al-Shabanah","year":"2013","unstructured":"Al-Shabanah OA, Hafez MM, Hassan ZK, Sayed-Ahmed MM, Abozeed WN, Al-Rejaie SS, et al. Human papillomavirus genotyping and integration in ovarian cancer Saudi patients. Virol J. 2013;10:343. https:\/\/doi.org\/10.1186\/1743-422x-10-343.","journal-title":"Virol J"},{"issue":"2","key":"473_CR330","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41391-021-00413-5","volume":"25","author":"J Javier-DesLoges","year":"2022","unstructured":"Javier-DesLoges J, McKay RR, Swafford AD, Sepich-Poore GD, Knight R, Parsons JK. The microbiome and prostate cancer. Prostate Cancer Prostatic Dis. 2022;25(2):159\u201364. https:\/\/doi.org\/10.1038\/s41391-021-00413-5.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"473_CR331","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.eururo.2017.03.029","volume":"72","author":"I Cavarretta","year":"2017","unstructured":"Cavarretta I, Ferrarese R, Cazzaniga W, Saita D, Lucian\u00f2 R, Ceresola ER, et al. The Microbiome of the Prostate Tumor Microenvironment. Eur Urol. 2017;72(4):625\u201331. https:\/\/doi.org\/10.1016\/j.eururo.2017.03.029.","journal-title":"Eur Urol"},{"issue":"1","key":"473_CR332","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01011-3","volume":"14","author":"PV Salachan","year":"2022","unstructured":"Salachan PV, Rasmussen M, Freds\u00f8e J, Ulh\u00f8i B, Borre M, S\u00f8rensen KD. Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling. Genome Med. 2022;14(1):9. https:\/\/doi.org\/10.1186\/s13073-022-01011-3.","journal-title":"Genome Med"},{"issue":"6","key":"473_CR333","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ajog.2016.09.075","volume":"215","author":"I Moreno","year":"2016","unstructured":"Moreno I, Codo\u00f1er FM, Vilella F, Valbuena D, Martinez-Blanch JF, Jimenez-Almaz\u00e1n J, et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol. 2016;215(6):684\u2013703. https:\/\/doi.org\/10.1016\/j.ajog.2016.09.075.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"473_CR334","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/ijc.33428","volume":"148","author":"W Lu","year":"2021","unstructured":"Lu W, He F, Lin Z, Liu S, Tang L, Huang Y, et al. Dysbiosis of the endometrial microbiota and its association with inflammatory cytokines in endometrial cancer. Int J Cancer. 2021;148(7):1708\u201316. https:\/\/doi.org\/10.1002\/ijc.33428.","journal-title":"Int J Cancer"},{"key":"473_CR335","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051109","author":"J Gonzalez-Bosquet","year":"2021","unstructured":"Gonzalez-Bosquet J, Pedra-Nobre S, Devor EJ, Thiel KW, Goodheart MJ, Bender DP, et al. Bacterial, archaea, and viral transcripts (BAVT) expression in gynecological cancers and correlation with regulatory regions of the genome. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13051109.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"473_CR336","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00934-6","volume":"8","author":"MT France","year":"2020","unstructured":"France MT, Ma B, Gajer P, Brown S, Humphrys MS, Holm JB, et al. VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition. Microbiome. 2020;8(1):166. https:\/\/doi.org\/10.1186\/s40168-020-00934-6.","journal-title":"Microbiome"},{"issue":"1","key":"473_CR337","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41467-022-28724-8","volume":"13","author":"A Lebeau","year":"2022","unstructured":"Lebeau A, Bruyere D, Roncarati P, Peixoto P, Hervouet E, Cobraiville G, et al. HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources. Nat Commun. 2022;13(1):1076. https:\/\/doi.org\/10.1038\/s41467-022-28724-8.","journal-title":"Nat Commun"},{"key":"473_CR338","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12154979","author":"IL Stoian","year":"2023","unstructured":"Stoian IL, Botezatu A, Fudulu A, Ilea CG, Socolov DG. Exploring microbiota diversity in cervical lesion progression and HPV infection through 16S rRNA gene metagenomic sequencing. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12154979.","journal-title":"J Clin Med"},{"issue":"12","key":"473_CR339","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1093\/infdis\/jiu004","volume":"209","author":"SY Doerflinger","year":"2014","unstructured":"Doerflinger SY, Throop AL, Herbst-Kralovetz MM. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J Infect Dis. 2014;209(12):1989\u201399. https:\/\/doi.org\/10.1093\/infdis\/jiu004.","journal-title":"J Infect Dis"},{"issue":"3","key":"473_CR340","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/2049-632x.12033","volume":"67","author":"SL Gellatly","year":"2013","unstructured":"Gellatly SL, Hancock RE. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis. 2013;67(3):159\u201373. https:\/\/doi.org\/10.1111\/2049-632x.12033.","journal-title":"Pathog Dis"},{"key":"473_CR341","doi-asserted-by":"publisher","first-page":"1574511","DOI":"10.3389\/fcimb.2025.1574511","volume":"15","author":"Y Guo","year":"2025","unstructured":"Guo Y, Xiao Y, Zhang C, Wang Y, Cao G, Tse KY, et al. The intratumoral microbiota heterogenicity is related to the prognosis and tumorigenesis of cervical cancer. Front Cell Infect Microbiol. 2025;15:1574511. https:\/\/doi.org\/10.3389\/fcimb.2025.1574511.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"473_CR342","doi-asserted-by":"publisher","first-page":"5","DOI":"10.20517\/mrr.2023.47","volume":"3","author":"Z Peng","year":"2024","unstructured":"Peng Z, Zhuang J, Shen B. The role of microbiota in tumorigenesis, progression and treatment of bladder cancer. Microbiome Res Rep. 2024;3(1):5. https:\/\/doi.org\/10.20517\/mrr.2023.47.","journal-title":"Microbiome Res Rep"},{"issue":"4","key":"473_CR343","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.70012","volume":"4","author":"N Li","year":"2025","unstructured":"Li N, Wang L, Yang Q, Li F, Shi Z, Feng X, et al. Identification and Evaluation of the Urinary Microbiota Associated With Bladder Cancer. Cancer Innov. 2025;4(4):e70012. https:\/\/doi.org\/10.1002\/cai2.70012.","journal-title":"Cancer Innov"},{"key":"473_CR344","doi-asserted-by":"publisher","unstructured":"Ece G, Akta\u015f A, Caner A, Sa\u011fl\u0131k \u0130, Kula Atik T, Ulusan Ba\u011fc\u0131 \u00d6, et al. The Urogenital System Microbiota: Is It a New Gamechanger in Urogenital Cancers? Microorganisms. 2025;13(2). https:\/\/doi.org\/10.3390\/microorganisms13020315","DOI":"10.3390\/microorganisms13020315"},{"issue":"2","key":"473_CR345","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13402-023-00876-9","volume":"47","author":"K Wu","year":"2024","unstructured":"Wu K, Li Y, Ma K, Zhao W, Yao Z, Zheng Z, et al. The microbiota and renal cell carcinoma. Cell Oncol (Dordr). 2024;47(2):397\u2013413. https:\/\/doi.org\/10.1007\/s13402-023-00876-9.","journal-title":"Cell Oncol (Dordr)"},{"issue":"4","key":"473_CR346","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrmicro2537","volume":"9","author":"EA Grice","year":"2011","unstructured":"Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244\u201353. https:\/\/doi.org\/10.1038\/nrmicro2537.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"473_CR347","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ccell.2021.04.008","volume":"39","author":"GD Sepich-Poore","year":"2021","unstructured":"Sepich-Poore GD, Carter H, Knight R. Intratumoral bacteria generate a new class of therapeutically relevant tumor antigens in melanoma. Cancer Cell. 2021;39(5):601\u20133. https:\/\/doi.org\/10.1016\/j.ccell.2021.04.008.","journal-title":"Cancer Cell"},{"issue":"2","key":"473_CR348","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aao4502","volume":"4","author":"T Nakatsuji","year":"2018","unstructured":"Nakatsuji T, Chen TH, Butcher AM, Trzoss LL, Nam SJ, Shirakawa KT, et al. A commensal strain of Staphylococcus epidermidis protects against skin neoplasia. Sci Adv. 2018;4(2):eaao4502. https:\/\/doi.org\/10.1126\/sciadv.aao4502.","journal-title":"Sci Adv"},{"issue":"5","key":"473_CR349","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2023.100482","volume":"4","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Gao Q, Ren X, Luo M, Liu Y, Liu P, et al. Characterization of intratumor microbiome in cancer immunotherapy. Innovation (Camb). 2023;4(5):100482. https:\/\/doi.org\/10.1016\/j.xinn.2023.100482.","journal-title":"Innovation (Camb)"},{"key":"473_CR350","doi-asserted-by":"publisher","unstructured":"Fahradyan A, Howell AC, Wolfswinkel EM, Tsuha M, Sheth P, Wong AK. Updates on the Management of Non-Melanoma Skin Cancer (NMSC). Healthcare (Basel). 2017;5(4). https:\/\/doi.org\/10.3390\/healthcare5040082","DOI":"10.3390\/healthcare5040082"},{"issue":"4","key":"473_CR351","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jaad.2014.01.857","volume":"70","author":"J Wang","year":"2014","unstructured":"Wang J, Aldabagh B, Yu J, Arron ST. Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis. J Am Acad Dermatol. 2014;70(4):621\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2014.01.857.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"473_CR352","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1002\/onco.13593","volume":"26","author":"ML Chen","year":"2021","unstructured":"Chen ML, Wang SH, Wei JC, Yip HT, Hung YM, Chang R. The impact of human papillomavirus infection on skin cancer: a population-based cohort study. Oncologist. 2021;26(3):e473\u201383. https:\/\/doi.org\/10.1002\/onco.13593.","journal-title":"Oncologist"},{"key":"473_CR353","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1426807","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Liu W, Wang M, Wang X, Wang S. Causal roles of skin microbiota in skin cancers suggested by genetic study. Front Microbiol. 2024;15:1426807. https:\/\/doi.org\/10.3389\/fmicb.2024.1426807.","journal-title":"Front Microbiol"},{"issue":"1","key":"473_CR354","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang N, Wu J, Wang Q, Liang Y, Li X, Chen G, et al. Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 2023;13(1):82. https:\/\/doi.org\/10.1038\/s41408-023-00853-3.","journal-title":"Blood Cancer J"},{"key":"473_CR355","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2022.100451","volume":"36","author":"CJF Heymann","year":"2022","unstructured":"Heymann CJF, Bobin-Dubigeon C, Mu\u00f1oz-Garcia J, Cochonneau D, Ollivier E, Heymann MF, et al. Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients. J Bone Oncol. 2022;36:100451. https:\/\/doi.org\/10.1016\/j.jbo.2022.100451.","journal-title":"J Bone Oncol"},{"issue":"5","key":"473_CR356","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00262-020-02508-9","volume":"69","author":"K Yahiro","year":"2020","unstructured":"Yahiro K, Matsumoto Y, Yamada H, Endo M, Setsu N, Fujiwara T, et al. Activation of TLR4 signaling inhibits progression of osteosarcoma by stimulating CD8-positive cytotoxic lymphocytes. Cancer Immunol Immunother. 2020;69(5):745\u201358. https:\/\/doi.org\/10.1007\/s00262-020-02508-9.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"473_CR357","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41392-021-00795-x","volume":"6","author":"Y Gao","year":"2021","unstructured":"Gao Y, Bi D, Xie R, Li M, Guo J, Liu H, et al. Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer. Signal Transduct Target Ther. 2021;6(1):398. https:\/\/doi.org\/10.1038\/s41392-021-00795-x.","journal-title":"Signal Transduct Target Ther"},{"key":"473_CR358","doi-asserted-by":"publisher","unstructured":"Pomella S, Cassandri M, Melaiu O, Marampon F, Gargari M, Campanella V, et al. DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma. Int J Mol Sci. 2023;24(3). https:\/\/doi.org\/10.3390\/ijms24032673","DOI":"10.3390\/ijms24032673"},{"issue":"1","key":"473_CR359","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2025.2465015","volume":"14","author":"R Roesel","year":"2025","unstructured":"Roesel R, Strati F, Basso C, Epistolio S, Spina P, Djordjevic J, et al. Combined tumor-associated microbiome and immune gene expression profiling predict response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer. Oncoimmunology. 2025;14(1):2465015. https:\/\/doi.org\/10.1080\/2162402x.2025.2465015.","journal-title":"Oncoimmunology"},{"issue":"10","key":"473_CR360","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.annonc.2020.06.003","volume":"31","author":"G Serna","year":"2020","unstructured":"Serna G, Ruiz-Pace F, Hernando J, Alonso L, Fasani R, Landolfi S, et al. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer. Ann Oncol. 2020;31(10):1366\u201375. https:\/\/doi.org\/10.1016\/j.annonc.2020.06.003.","journal-title":"Ann Oncol"},{"key":"473_CR361","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201915","author":"K Yang","year":"2021","unstructured":"Yang K, Hou Y, Zhang Y, Liang H, Sharma A, Zheng W, et al. Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiation. J Exp Med. 2021. https:\/\/doi.org\/10.1084\/jem.20201915.","journal-title":"J Exp Med"},{"issue":"5","key":"473_CR362","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng L, Liang H, Xu M, Yang X, Burnette B, Arina A, et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity. 2014;41(5):843\u201352. https:\/\/doi.org\/10.1016\/j.immuni.2014.10.019.","journal-title":"Immunity"},{"issue":"1","key":"473_CR363","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-01735-9","volume":"16","author":"J Liu","year":"2021","unstructured":"Liu J, Liu C, Yue J. Radiotherapy and the gut microbiome: facts and fiction. Radiat Oncol. 2021;16(1):9. https:\/\/doi.org\/10.1186\/s13014-020-01735-9.","journal-title":"Radiat Oncol"},{"issue":"1","key":"473_CR364","doi-asserted-by":"publisher","first-page":"43","DOI":"10.20892\/j.issn.2095-3941.2020.0476","volume":"19","author":"J Dong","year":"2021","unstructured":"Dong J, Li Y, Xiao H, Cui M, Fan S. Commensal microbiota in the digestive tract: a review of its roles in carcinogenesis and radiotherapy. Cancer Biol Med. 2021;19(1):43\u201355. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0476.","journal-title":"Cancer Biol Med"},{"key":"473_CR365","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102442","volume":"109","author":"M Reis Ferreira","year":"2022","unstructured":"Reis Ferreira M, Pasto A, Ng T, Patel V, Guerrero Urbano T, Sears C, et al. The microbiota and radiotherapy for head and neck cancer: what should clinical oncologists know? Cancer Treat Rev. 2022;109:102442. https:\/\/doi.org\/10.1016\/j.ctrv.2022.102442.","journal-title":"Cancer Treat Rev"},{"issue":"17","key":"473_CR366","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179451","volume":"22","author":"A Ramos","year":"2021","unstructured":"Ramos A, Sadeghi S, Tabatabaeian H. Battling chemoresistance in cancer: root causes and strategies to uproot them. Int J Mol Sci. 2021;22(17):9451. https:\/\/doi.org\/10.3390\/ijms22179451.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"473_CR367","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092583","volume":"15","author":"G Pani","year":"2023","unstructured":"Pani G. Fusobacterium & Co. at the stem of cancer: microbe-cancer stem cell interactions in colorectal carcinogenesis. Cancers (Basel). 2023;15(9):2583. https:\/\/doi.org\/10.3390\/cancers15092583.","journal-title":"Cancers (Basel)"},{"issue":"21","key":"473_CR368","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202206370","volume":"35","author":"W Zhen","year":"2023","unstructured":"Zhen W, Weichselbaum RR, Lin W. Nanoparticle-mediated radiotherapy remodels the tumor microenvironment to enhance antitumor efficacy. Adv Mater. 2023;35(21):e2206370. https:\/\/doi.org\/10.1002\/adma.202206370.","journal-title":"Adv Mater"},{"key":"473_CR369","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-019-0074-5","volume":"4","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Tang H, Chen P, Xie H, Tao Y. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome. Signal Transduct Target Ther. 2019;4:41. https:\/\/doi.org\/10.1038\/s41392-019-0074-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"473_CR370","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032769","volume":"24","author":"D Dora","year":"2023","unstructured":"Dora D, Bokhari SMZ, Aloss K, Takacs P, Desnoix JZ, Szklen\u00e1rik G, et al. Implication of the gut microbiome and microbial-derived metabolites in immune-related adverse events: emergence of novel biomarkers for cancer immunotherapy. Int J Mol Sci. 2023;24(3):2769. https:\/\/doi.org\/10.3390\/ijms24032769.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"473_CR371","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102306","volume":"6","author":"J Chen","year":"2025","unstructured":"Chen J, Gao Y, Chen Y, Wang Q, Zhang Y, Huang Y, et al. Identification and validation of intratumoral microbiome associated with sensitization to immune checkpoint inhibitors. Cell Rep Med. 2025;6(9):102306. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102306.","journal-title":"Cell Rep Med"},{"issue":"1","key":"473_CR372","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-023-01492-8","volume":"16","author":"P Zhang","year":"2023","unstructured":"Zhang P, Zhang G, Wan X. Challenges and new technologies in adoptive cell therapy. J Hematol Oncol. 2023;16(1):97. https:\/\/doi.org\/10.1186\/s13045-023-01492-8.","journal-title":"J Hematol Oncol"},{"issue":"6230","key":"473_CR373","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348(6230):56\u201361. https:\/\/doi.org\/10.1126\/science.aaa8172.","journal-title":"Science"},{"issue":"1","key":"473_CR374","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/ppo.0000000000000240","volume":"23","author":"E Merhavi-Shoham","year":"2017","unstructured":"Merhavi-Shoham E, Itzhaki O, Markel G, Schachter J, Besser MJ. Adoptive cell therapy for metastatic melanoma. Cancer J. 2017;23(1):48\u201353. https:\/\/doi.org\/10.1097\/ppo.0000000000000240.","journal-title":"Cancer J"},{"issue":"1","key":"473_CR375","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00281-018-0703-z","volume":"41","author":"\u00d6 Met","year":"2019","unstructured":"Met \u00d6, Jensen KM, Chamberlain CA, Donia M, Svane IM. Principles of adoptive T cell therapy in cancer. Semin Immunopathol. 2019;41(1):49\u201358. https:\/\/doi.org\/10.1007\/s00281-018-0703-z.","journal-title":"Semin Immunopathol"},{"issue":"3","key":"473_CR376","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ymthe.2023.01.012","volume":"31","author":"M Uribe-Herranz","year":"2023","unstructured":"Uribe-Herranz M, Beghi S, Ruella M, Parvathaneni K, Salaris S, Kostopoulos N, et al. Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy. Mol Ther. 2023;31(3):686\u2013700. https:\/\/doi.org\/10.1016\/j.ymthe.2023.01.012.","journal-title":"Mol Ther"},{"issue":"6667","key":"473_CR377","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.add7034","volume":"382","author":"RL Vincent","year":"2023","unstructured":"Vincent RL, Gurbatri CR, Li F, Vardoshvili A, Coker C, Im J, et al. Probiotic-guided CAR-T cells for solid tumor targeting. Science. 2023;382(6667):211\u20138. https:\/\/doi.org\/10.1126\/science.add7034.","journal-title":"Science"},{"key":"473_CR378","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/ijn.S114477","volume":"12","author":"N Hanagata","year":"2017","unstructured":"Hanagata N. CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies. Int J Nanomedicine. 2017;12:515\u201331. https:\/\/doi.org\/10.2147\/ijn.S114477.","journal-title":"Int J Nanomedicine"},{"issue":"6161","key":"473_CR379","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342(6161):967\u201370. https:\/\/doi.org\/10.1126\/science.1240527.","journal-title":"Science"},{"issue":"6344","key":"473_CR380","doi-asserted-by":"publisher","DOI":"10.1126\/science.aag2770","volume":"356","author":"N Koppel","year":"2017","unstructured":"Koppel N, Maini Rekdal V, Balskus EP. Chemical transformation of xenobiotics by the human gut microbiota. Science. 2017;356(6344):aag2770. https:\/\/doi.org\/10.1126\/science.aag2770.","journal-title":"Science"},{"issue":"4","key":"473_CR381","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041447","volume":"21","author":"M Matsushita","year":"2020","unstructured":"Matsushita M, Fujita K, Nonomura N. Influence of diet and nutrition on prostate cancer. Int J Mol Sci. 2020;21(4):1447. https:\/\/doi.org\/10.3390\/ijms21041447.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"473_CR382","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41568-019-0227-4","volume":"20","author":"SE Steck","year":"2020","unstructured":"Steck SE, Murphy EA. Dietary patterns and cancer risk. Nat Rev Cancer. 2020;20(2):125\u201338. https:\/\/doi.org\/10.1038\/s41568-019-0227-4.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"473_CR383","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.05.041.","journal-title":"Cell"},{"issue":"2","key":"473_CR384","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.trecan.2024.11.003","volume":"11","author":"S Li","year":"2025","unstructured":"Li S, Duan Y, Luo S, Zhou F, Wu Q, Lu Z. Short-chain fatty acids and cancer. Trends Cancer. 2025;11(2):154\u201368. https:\/\/doi.org\/10.1016\/j.trecan.2024.11.003.","journal-title":"Trends Cancer"},{"issue":"6","key":"473_CR385","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.celrep.2020.01.035","volume":"30","author":"Y Li","year":"2020","unstructured":"Li Y, Elm\u00e9n L, Segota I, Xian Y, Tinoco R, Feng Y, et al. Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth. Cell Rep. 2020;30(6):1753-66.e6. https:\/\/doi.org\/10.1016\/j.celrep.2020.01.035.","journal-title":"Cell Rep"},{"key":"473_CR386","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101754","volume":"67","author":"R Jamal","year":"2023","unstructured":"Jamal R, Messaoudene M, de Figuieredo M, Routy B. Future indications and clinical management for fecal microbiota transplantation (FMT) in immuno-oncology. Semin Immunol. 2023;67:101754. https:\/\/doi.org\/10.1016\/j.smim.2023.101754.","journal-title":"Semin Immunol"},{"issue":"6529","key":"473_CR387","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin JM, Morrison RM, et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science. 2021;371(6529):595\u2013602. https:\/\/doi.org\/10.1126\/science.abf3363.","journal-title":"Science"},{"issue":"12","key":"473_CR388","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/s41591-018-0238-9","volume":"24","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wiesnoski DH, Helmink BA, Gopalakrishnan V, Choi K, DuPont HL, et al. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat Med. 2018;24(12):1804\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0238-9.","journal-title":"Nat Med"},{"key":"473_CR389","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ebiom.2019.03.070","volume":"44","author":"HR Wardill","year":"2019","unstructured":"Wardill HR, Secombe KR, Bryant RV, Hazenberg MD, Costello SP. Adjunctive fecal microbiota transplantation in supportive oncology: emerging indications and considerations in immunocompromised patients. EBioMedicine. 2019;44:730\u201340. https:\/\/doi.org\/10.1016\/j.ebiom.2019.03.070.","journal-title":"EBioMedicine"},{"key":"473_CR390","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2019.03.010","volume":"452","author":"X Wu","year":"2019","unstructured":"Wu X, Zhang T, Chen X, Ji G, Zhang F. Microbiota transplantation: targeting cancer treatment. Cancer Lett. 2019;452:144\u201351. https:\/\/doi.org\/10.1016\/j.canlet.2019.03.010.","journal-title":"Cancer Lett"},{"issue":"15","key":"473_CR391","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1002\/cam4.3870","volume":"10","author":"C Mohindroo","year":"2021","unstructured":"Mohindroo C, Hasanov M, Rogers JE, Dong W, Prakash LR, Baydogan S, et al. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients. Cancer Med. 2021;10(15):5041\u201350. https:\/\/doi.org\/10.1002\/cam4.3870.","journal-title":"Cancer Med"},{"key":"473_CR392","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216041","volume":"555","author":"G Bernardo","year":"2023","unstructured":"Bernardo G, Le Noci V, Ottaviano E, De Cecco L, Camisaschi C, Guglielmetti S, et al. Reduction of Staphylococcus epidermidis in the mammary tumor microbiota induces antitumor immunity and decreases breast cancer aggressiveness. Cancer Lett. 2023;555:216041. https:\/\/doi.org\/10.1016\/j.canlet.2022.216041.","journal-title":"Cancer Lett"},{"issue":"8","key":"473_CR393","doi-asserted-by":"publisher","first-page":"7335","DOI":"10.1021\/acsnano.2c11305","volume":"17","author":"C Gao","year":"2023","unstructured":"Gao C, Wang X, Yang B, Yuan W, Huang W, Wu G, et al. Synergistic Target of Intratumoral Microbiome and Tumor by Metronidazole-Fluorouridine Nanoparticles. ACS Nano. 2023;17(8):7335\u201351. https:\/\/doi.org\/10.1021\/acsnano.2c11305.","journal-title":"ACS Nano"},{"issue":"7","key":"473_CR394","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jtho.2020.03.002","volume":"15","author":"L Lurienne","year":"2020","unstructured":"Lurienne L, Cervesi J, Duhalde L, de Gunzburg J, Andremont A, Zalcman G, et al. NSCLC Immunotherapy Efficacy and Antibiotic Use: A Systematic Review and Meta-Analysis. J Thorac Oncol. 2020;15(7):1147\u201359. https:\/\/doi.org\/10.1016\/j.jtho.2020.03.002.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"473_CR395","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003779","volume":"10","author":"Y Jing","year":"2022","unstructured":"Jing Y, Chen X, Li K, Liu Y, Zhang Z, Chen Y, et al. Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy. J Immunother Cancer. 2022;10(1):003779. https:\/\/doi.org\/10.1136\/jitc-2021-003779.","journal-title":"J Immunother Cancer"},{"issue":"7706","key":"473_CR396","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41586-018-0125-z","volume":"557","author":"M Meisel","year":"2018","unstructured":"Meisel M, Hinterleitner R, Pacis A, Chen L, Earley ZM, Mayassi T, et al. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature. 2018;557(7706):580\u20134. https:\/\/doi.org\/10.1038\/s41586-018-0125-z.","journal-title":"Nature"},{"issue":"12","key":"473_CR397","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1001\/jamaoncol.2019.2785","volume":"5","author":"DJ Pinato","year":"2019","unstructured":"Pinato DJ, Howlett S, Ottaviani D, Urus H, Patel A, Mineo T, et al. Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer. JAMA Oncol. 2019;5(12):1774\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2019.2785.","journal-title":"JAMA Oncol"},{"issue":"2","key":"473_CR398","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","volume":"4","author":"JM Munita","year":"2016","unstructured":"Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr. 2016;4(2):VMBF-0016-2015. https:\/\/doi.org\/10.1128\/microbiolspec.VMBF-0016-2015.","journal-title":"Microbiol Spectr"},{"issue":"17","key":"473_CR399","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1016\/j.ejca.2015.08.015","volume":"51","author":"B Boursi","year":"2015","unstructured":"Boursi B, Mamtani R, Haynes K, Yang YX. Recurrent antibiotic exposure may promote cancer formation--Another step in understanding the role of the human microbiota? Eur J Cancer. 2015;51(17):2655\u201364. https:\/\/doi.org\/10.1016\/j.ejca.2015.08.015.","journal-title":"Eur J Cancer"},{"issue":"4","key":"473_CR400","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","volume":"35","author":"N H\u00f8iby","year":"2010","unstructured":"H\u00f8iby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35(4):322\u201332. https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.12.011.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"473_CR401","doi-asserted-by":"publisher","DOI":"10.3390\/v9060150","volume":"9","author":"E Jo\u0144czyk-Matysiak","year":"2017","unstructured":"Jo\u0144czyk-Matysiak E, Weber-D\u0105browska B, Owczarek B, Mi\u0119dzybrodzki R, \u0141usiak-Szelachowska M, \u0141odej N, et al. Phage-phagocyte interactions and their implications for phage application as therapeutics. Viruses. 2017;9(6):0150. https:\/\/doi.org\/10.3390\/v9060150.","journal-title":"Viruses"},{"issue":"4","key":"473_CR402","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6040086","volume":"6","author":"A Paule","year":"2018","unstructured":"Paule A, Frezza D, Edeas M. Microbiota and phage therapy: future challenges in medicine. Med Sci (Basel). 2018;6(4):0086. https:\/\/doi.org\/10.3390\/medsci6040086.","journal-title":"Med Sci (Basel)"},{"issue":"1","key":"473_CR403","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1038\/s41467-020-16967-2","volume":"11","author":"L Parhi","year":"2020","unstructured":"Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun. 2020;11(1):3259. https:\/\/doi.org\/10.1038\/s41467-020-16967-2.","journal-title":"Nat Commun"},{"issue":"9","key":"473_CR404","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41551-019-0423-2","volume":"3","author":"DW Zheng","year":"2019","unstructured":"Zheng DW, Dong X, Pan P, Chen KW, Fan JX, Cheng SX, et al. Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy. Nat Biomed Eng. 2019;3(9):717\u201328. https:\/\/doi.org\/10.1038\/s41551-019-0423-2.","journal-title":"Nat Biomed Eng"},{"issue":"20","key":"473_CR405","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1590","volume":"6","author":"X Dong","year":"2020","unstructured":"Dong X, Pan P, Zheng DW, Bao P, Zeng X, Zhang XZ. Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer. Sci Adv. 2020;6(20):eaba1590. https:\/\/doi.org\/10.1126\/sciadv.aba1590.","journal-title":"Sci Adv"},{"key":"473_CR406","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119984","volume":"247","author":"S Gurung","year":"2020","unstructured":"Gurung S, Khan F, Gunassekaran GR, Yoo JD, Poongkavithai Vadevoo SM, Permpoon U, et al. Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression. Biomaterials. 2020;247:119984. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119984.","journal-title":"Biomaterials"},{"key":"473_CR407","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14164054","author":"J Wang","year":"2022","unstructured":"Wang J, Lamolinara A, Conti L, Giangrossi M, Cui L, Morelli MB, et al. HER2-displaying M13 bacteriophages induce therapeutic immunity against breast cancer. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14164054.","journal-title":"Cancers (Basel)"},{"key":"473_CR408","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-med-080219-122208","volume":"73","author":"GF Hatfull","year":"2022","unstructured":"Hatfull GF, Dedrick RM, Schooley RT. Phage therapy for antibiotic-resistant bacterial infections. Annu Rev Med. 2022;73:197\u2013211. https:\/\/doi.org\/10.1146\/annurev-med-080219-122208.","journal-title":"Annu Rev Med"},{"issue":"3","key":"473_CR409","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4161\/gmic.23919","volume":"4","author":"M Raman","year":"2013","unstructured":"Raman M, Ambalam P, Kondepudi KK, Pithva S, Kothari C, Patel AT, et al. Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut Microbes. 2013;4(3):181\u201392. https:\/\/doi.org\/10.4161\/gmic.23919.","journal-title":"Gut Microbes"},{"issue":"5","key":"473_CR410","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1159\/000345580","volume":"29","author":"K Peitsidou","year":"2012","unstructured":"Peitsidou K, Karantanos T, Theodoropoulos GE. Probiotics, prebiotics, synbiotics: is there enough evidence to support their use in colorectal cancer surgery? Dig Surg. 2012;29(5):426\u201338. https:\/\/doi.org\/10.1159\/000345580.","journal-title":"Dig Surg"},{"issue":"11","key":"473_CR411","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nrc2934","volume":"10","author":"NS Forbes","year":"2010","unstructured":"Forbes NS. Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer. 2010;10(11):785\u201394. https:\/\/doi.org\/10.1038\/nrc2934.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"473_CR412","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s13139-016-0415-z","volume":"51","author":"VH Nguyen","year":"2017","unstructured":"Nguyen VH, Min JJ. Salmonella-mediated cancer therapy: roles and potential. Nucl Med Mol Imaging. 2017;51(2):118\u201326. https:\/\/doi.org\/10.1007\/s13139-016-0415-z.","journal-title":"Nucl Med Mol Imaging"},{"issue":"2","key":"473_CR413","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/cgt.2012.86","volume":"20","author":"X Yin","year":"2013","unstructured":"Yin X, Yu B, Tang Z, He B, Ren J, Xiao X, et al. Bifidobacterium infantis-mediated HSV-TK\/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer. Cancer Gene Ther. 2013;20(2):77\u201381. https:\/\/doi.org\/10.1038\/cgt.2012.86.","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"473_CR414","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/1078-0432.Ccr-20-2065","volume":"27","author":"F Janku","year":"2021","unstructured":"Janku F, Zhang HH, Pezeshki A, Goel S, Murthy R, Wang-Gillam A, et al. Intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory advanced solid tumors. Clin Cancer Res. 2021;27(1):96\u2013106. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-2065.","journal-title":"Clin Cancer Res"},{"key":"473_CR415","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-24-3952","author":"BE Nelson","year":"2025","unstructured":"Nelson BE, Janku F, Fu S, Dumbrava EE, Hong DS, Karp DD, et al. Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors. Clin Cancer Res. 2025. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-24-3952.","journal-title":"Clin Cancer Res"},{"issue":"7614","key":"473_CR416","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nature18930","volume":"536","author":"MO Din","year":"2016","unstructured":"Din MO, Danino T, Prindle A, Skalak M, Selimkhanov J, Allen K, et al. Synchronized cycles of bacterial lysis for in vivo delivery. Nature. 2016;536(7614):81\u20135. https:\/\/doi.org\/10.1038\/nature18930.","journal-title":"Nature"},{"key":"473_CR417","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax0876","author":"CR Gurbatri","year":"2020","unstructured":"Gurbatri CR, Lia I, Vincent R, Coker C, Castro S, Treuting PM, et al. Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies. Sci Transl Med. 2020. https:\/\/doi.org\/10.1126\/scitranslmed.aax0876.","journal-title":"Sci Transl Med"},{"issue":"Pt A","key":"473_CR418","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2016.09.007","volume":"106","author":"Z Hosseinidoust","year":"2016","unstructured":"Hosseinidoust Z, Mostaghaci B, Yasa O, Park BW, Singh AV, Sitti M. Bioengineered and biohybrid bacteria-based systems for drug delivery. Adv Drug Deliv Rev. 2016;106(Pt A):27\u201344. https:\/\/doi.org\/10.1016\/j.addr.2016.09.007.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"473_CR419","doi-asserted-by":"publisher","first-page":"9801","DOI":"10.1038\/s41598-018-28102-9","volume":"8","author":"O Schauer","year":"2018","unstructured":"Schauer O, Mostaghaci B, Colin R, H\u00fcrtgen D, Kraus D, Sitti M, et al. Motility and chemotaxis of bacteria-driven microswimmers fabricated using antigen 43-mediated biotin display. Sci Rep. 2018;8(1):9801. https:\/\/doi.org\/10.1038\/s41598-018-28102-9.","journal-title":"Sci Rep"},{"issue":"7882","key":"473_CR420","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41586-021-04003-2","volume":"598","author":"FP Canale","year":"2021","unstructured":"Canale FP, Basso C, Antonini G, Perotti M, Li N, Sokolovska A, et al. Metabolic modulation of tumours with engineered bacteria for immunotherapy. Nature. 2021;598(7882):662\u20136. https:\/\/doi.org\/10.1038\/s41586-021-04003-2.","journal-title":"Nature"},{"issue":"1","key":"473_CR421","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44776-4","volume":"15","author":"CR Gurbatri","year":"2024","unstructured":"Gurbatri CR, Radford GA, Vrbanac L, Im J, Thomas EM, Coker C, et al. Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia. Nat Commun. 2024;15(1):646. https:\/\/doi.org\/10.1038\/s41467-024-44776-4.","journal-title":"Nat Commun"},{"key":"473_CR422","doi-asserted-by":"publisher","unstructured":"Rizzi S, Wensink MJ, Lindahl-Jacobsen R, Tian L, Lu Y, Eisenberg M. Risk of pre-term births and major birth defects resulting from paternal intake of COVID-19 medications prior to conception. Res Sq. 2020. https:\/\/doi.org\/10.21203\/rs.3.rs-59420\/v2","DOI":"10.21203\/rs.3.rs-59420\/v2"},{"key":"473_CR423","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9537","author":"JH Zheng","year":"2017","unstructured":"Zheng JH, Nguyen VH, Jiang SN, Park SH, Tan W, Hong SH, et al. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aak9537.","journal-title":"Sci Transl Med"},{"issue":"1","key":"473_CR424","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-023-01693-0","volume":"9","author":"Y Cao","year":"2024","unstructured":"Cao Y, Xia H, Tan X, Shi C, Ma Y, Meng D, et al. Intratumoural microbiota: a new frontier in cancer development and therapy. Signal Transduct Target Ther. 2024;9(1):15. https:\/\/doi.org\/10.1038\/s41392-023-01693-0.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"473_CR425","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","volume":"25","author":"S Chowdhury","year":"2019","unstructured":"Chowdhury S, Castro S, Coker C, Hinchliffe TE, Arpaia N, Danino T. Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nat Med. 2019;25(7):1057\u201363. https:\/\/doi.org\/10.1038\/s41591-019-0498-z.","journal-title":"Nat Med"},{"issue":"12","key":"473_CR426","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","volume":"18","author":"S Zhou","year":"2018","unstructured":"Zhou S, Gravekamp C, Bermudes D, Liu K. Tumour-targeting bacteria engineered to fight cancer. Nat Rev Cancer. 2018;18(12):727\u201343. https:\/\/doi.org\/10.1038\/s41568-018-0070-z.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"473_CR427","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41551-021-00834-6","volume":"6","author":"W Wang","year":"2022","unstructured":"Wang W, Xu H, Ye Q, Tao F, Wheeldon I, Yuan A, et al. Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria. Nat Biomed Eng. 2022;6(1):44\u201353. https:\/\/doi.org\/10.1038\/s41551-021-00834-6.","journal-title":"Nat Biomed Eng"},{"key":"473_CR428","doi-asserted-by":"publisher","DOI":"10.1038\/srep00436","volume":"2","author":"B Yu","year":"2012","unstructured":"Yu B, Yang M, Shi L, Yao Y, Jiang Q, Li X, et al. Explicit hypoxia targeting with tumor suppression by creating an \u201cobligate\u201d anaerobic Salmonella Typhimurium strain. Sci Rep. 2012;2:436. https:\/\/doi.org\/10.1038\/srep00436.","journal-title":"Sci Rep"},{"issue":"1","key":"473_CR429","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41551-017-0181-y","volume":"2","author":"CL Ho","year":"2018","unstructured":"Ho CL, Tan HQ, Chua KJ, Kang A, Lim KH, Ling KL, et al. Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention. Nat Biomed Eng. 2018;2(1):27\u201337. https:\/\/doi.org\/10.1038\/s41551-017-0181-y.","journal-title":"Nat Biomed Eng"},{"issue":"10","key":"473_CR430","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.7150\/thno.16135","volume":"6","author":"SH Park","year":"2016","unstructured":"Park SH, Zheng JH, Nguyen VH, Jiang SN, Kim DY, Szardenings M, et al. RGD peptide cell-surface display enhances the targeting and therapeutic efficacy of attenuated Salmonella-mediated cancer therapy. Theranostics. 2016;6(10):1672\u201382. https:\/\/doi.org\/10.7150\/thno.16135.","journal-title":"Theranostics"},{"issue":"5","key":"473_CR431","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1182\/blood-2012-12-474098","volume":"122","author":"PE Massa","year":"2013","unstructured":"Massa PE, Paniccia A, Monegal A, de Marco A, Rescigno M. Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas. Blood. 2013;122(5):705\u201314. https:\/\/doi.org\/10.1182\/blood-2012-12-474098.","journal-title":"Blood"},{"issue":"1","key":"473_CR432","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26956-8","volume":"12","author":"Z Geng","year":"2021","unstructured":"Geng Z, Cao Z, Liu R, Liu K, Liu J, Tan W. Aptamer-assisted tumor localization of bacteria for enhanced biotherapy. Nat Commun. 2021;12(1):6584. https:\/\/doi.org\/10.1038\/s41467-021-26956-8.","journal-title":"Nat Commun"},{"key":"473_CR433","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbrc.2022.03.049","volume":"606","author":"Y Du","year":"2022","unstructured":"Du Y, Lin L, Zhang Z, Tang Y, Ou X, Wang Y, et al. Drug-loaded nanoparticles conjugated with genetically engineered bacteria for cancer therapy. Biochem Biophys Res Commun. 2022;606:29\u201334. https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.049.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"473_CR434","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/bjc.2014.486","volume":"111","author":"M Singh","year":"2014","unstructured":"Singh M, Quispe-Tintaya W, Chandra D, Jahangir A, Venkataswamy MM, Ng TW, et al. Direct incorporation of the NKT-cell activator \u03b1-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy. Br J Cancer. 2014;111(10):1945\u201354. https:\/\/doi.org\/10.1038\/bjc.2014.486.","journal-title":"Br J Cancer"},{"key":"473_CR435","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112443","volume":"145","author":"J Chen","year":"2022","unstructured":"Chen J, Li T, Liang J, Huang Q, Huang JD, Ke Y, et al. Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy. Biomed Pharmacother. 2022;145:112443. https:\/\/doi.org\/10.1016\/j.biopha.2021.112443.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"473_CR436","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/cas.13027","volume":"107","author":"H Fukuhara","year":"2016","unstructured":"Fukuhara H, Ino Y, Todo T. Oncolytic virus therapy: a new era of cancer treatment at dawn. Cancer Sci. 2016;107(10):1373\u20139. https:\/\/doi.org\/10.1111\/cas.13027.","journal-title":"Cancer Sci"},{"issue":"3","key":"473_CR437","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.soc.2019.02.007","volume":"28","author":"ML Hennessy","year":"2019","unstructured":"Hennessy ML, Bommareddy PK, Boland G, Kaufman HL. Oncolytic immunotherapy. Surg Oncol Clin N Am. 2019;28(3):419\u201330. https:\/\/doi.org\/10.1016\/j.soc.2019.02.007.","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"473_CR438","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/mt.2011.276","volume":"20","author":"KA Parato","year":"2012","unstructured":"Parato KA, Breitbach CJ, Le Boeuf F, Wang J, Storbeck C, Ilkow C, et al. The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers. Mol Ther. 2012;20(4):749\u201358. https:\/\/doi.org\/10.1038\/mt.2011.276.","journal-title":"Mol Ther"},{"key":"473_CR439","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14447","volume":"8","author":"H Kalkavan","year":"2017","unstructured":"Kalkavan H, Sharma P, Kasper S, Helfrich I, Pandyra AA, Gassa A, et al. Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression. Nat Commun. 2017;8:14447. https:\/\/doi.org\/10.1038\/ncomms14447.","journal-title":"Nat Commun"},{"issue":"14","key":"473_CR440","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.7150\/thno.56494","volume":"11","author":"L Chen","year":"2021","unstructured":"Chen L, Chen H, Ye J, Ge Y, Wang H, Dai E, et al. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation. Theranostics. 2021;11(14):6668\u201381. https:\/\/doi.org\/10.7150\/thno.56494.","journal-title":"Theranostics"},{"key":"473_CR441","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.copbio.2019.11.016","volume":"65","author":"E Yl\u00f6sm\u00e4ki","year":"2020","unstructured":"Yl\u00f6sm\u00e4ki E, Cerullo V. Design and application of oncolytic viruses for cancer immunotherapy. Curr Opin Biotechnol. 2020;65:25\u201336. https:\/\/doi.org\/10.1016\/j.copbio.2019.11.016.","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"473_CR442","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1038\/s41467-018-07344-1","volume":"9","author":"L Russell","year":"2018","unstructured":"Russell L, Swanner J, Jaime-Ramirez AC, Wang Y, Sprague A, Banasavadi-Siddegowda Y, et al. PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance. Nat Commun. 2018;9(1):5006. https:\/\/doi.org\/10.1038\/s41467-018-07344-1.","journal-title":"Nat Commun"},{"issue":"13","key":"473_CR443","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202104763","volume":"18","author":"FHN Howard","year":"2022","unstructured":"Howard FHN, Al-Janabi H, Patel P, Cox K, Smith E, Vadakekolathu J, et al. Nanobugs as Drugs: Bacterial Derived Nanomagnets Enhance Tumor Targeting and Oncolytic Activity of HSV-1 Virus. Small. 2022;18(13):e2104763. https:\/\/doi.org\/10.1002\/smll.202104763.","journal-title":"Small"},{"issue":"1","key":"473_CR444","doi-asserted-by":"publisher","first-page":"1747206","DOI":"10.1080\/20013078.2020.1747206","volume":"9","author":"H Saari","year":"2020","unstructured":"Saari H, Turunen T, L\u00f5hmus A, Turunen M, Jalasvuori M, Butcher SJ, et al. Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery. J Extracell Vesicles. 2020;9(1):1747206. https:\/\/doi.org\/10.1080\/20013078.2020.1747206.","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"473_CR445","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/s1470-2045(21)00245-x","volume":"22","author":"J Fares","year":"2021","unstructured":"Fares J, Ahmed AU, Ulasov IV, Sonabend AM, Miska J, Lee-Chang C, et al. Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial. Lancet Oncol. 2021;22(8):1103\u201314. https:\/\/doi.org\/10.1016\/s1470-2045(21)00245-x.","journal-title":"Lancet Oncol"},{"issue":"12","key":"473_CR446","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/s41419-020-03285-0","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Cai J, Liu W, Lin Y, Guo L, Liu X, et al. Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade. Cell Death Dis. 2020;11(12):1062. https:\/\/doi.org\/10.1038\/s41419-020-03285-0.","journal-title":"Cell Death Dis"},{"issue":"4","key":"473_CR447","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/21645515.2017.1412896","volume":"14","author":"RM Conry","year":"2018","unstructured":"Conry RM, Westbrook B, McKee S, Norwood TG. Talimogene laherparepvec: first in class oncolytic virotherapy. Hum Vaccin Immunother. 2018;14(4):839\u201346. https:\/\/doi.org\/10.1080\/21645515.2017.1412896.","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"473_CR448","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1136\/bjophthalmol-2011-301470","volume":"96","author":"X Huang","year":"2012","unstructured":"Huang X, Jia R, Zhao X, Liu B, Wang H, Wang J, et al. Recombinant oncolytic adenovirus H101 combined with siBCL2: cytotoxic effect on uveal melanoma cell lines. Br J Ophthalmol. 2012;96(10):1331\u20138. https:\/\/doi.org\/10.1136\/bjophthalmol-2011-301470.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"473_CR449","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41591-022-01897-x","volume":"28","author":"T Todo","year":"2022","unstructured":"Todo T, Ito H, Ino Y, Ohtsu H, Ota Y, Shibahara J, et al. Intratumoral oncolytic herpes virus G47\u2206 for residual or recurrent glioblastoma: a phase 2 trial. Nat Med. 2022;28(8):1630\u20139. https:\/\/doi.org\/10.1038\/s41591-022-01897-x.","journal-title":"Nat Med"},{"issue":"14","key":"473_CR450","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/jco.2017.75.8219","volume":"36","author":"FF Lang","year":"2018","unstructured":"Lang FF, Conrad C, Gomez-Manzano C, Yung WKA, Sawaya R, Weinberg JS, et al. Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. J Clin Oncol. 2018;36(14):1419\u201327. https:\/\/doi.org\/10.1200\/jco.2017.75.8219.","journal-title":"J Clin Oncol"},{"issue":"1","key":"473_CR451","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","volume":"8","author":"L Yang","year":"2023","unstructured":"Yang L, Li A, Wang Y, Zhang Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduct Target Ther. 2023;8(1):35. https:\/\/doi.org\/10.1038\/s41392-022-01304-4.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"473_CR452","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/s1470-2045(15)00483-0","volume":"17","author":"E Quoix","year":"2016","unstructured":"Quoix E, Lena H, Losonczy G, Forget F, Chouaid C, Papai Z, et al. TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b\/3 trial. Lancet Oncol. 2016;17(2):212\u201323. https:\/\/doi.org\/10.1016\/s1470-2045(15)00483-0.","journal-title":"Lancet Oncol"},{"issue":"1","key":"473_CR453","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/ijc.28350","volume":"134","author":"T Weiland","year":"2014","unstructured":"Weiland T, Lampe J, Essmann F, Venturelli S, Berger A, Bossow S, et al. Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses. Int J Cancer. 2014;134(1):235\u201343. https:\/\/doi.org\/10.1002\/ijc.28350.","journal-title":"Int J Cancer"},{"issue":"7","key":"473_CR454","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41564-025-02035-2","volume":"10","author":"N Fierer","year":"2025","unstructured":"Fierer N, Leung PM, Lappan R, Eisenhofer R, Ricci F, Holland SI, et al. Guidelines for preventing and reporting contamination in low-biomass microbiome studies. Nat Microbiol. 2025;10(7):1570\u201380. https:\/\/doi.org\/10.1038\/s41564-025-02035-2.","journal-title":"Nat Microbiol"},{"issue":"9","key":"473_CR455","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1038\/s41592-025-02807-y","volume":"22","author":"Y Li","year":"2025","unstructured":"Li Y, Ma A, Johnson E, Eng C, De S, Jiang S, et al. The new microbiome on the block: challenges and opportunities of using human tumor sequencing data to study microbes. Nat Methods. 2025;22(9):1788\u201399. https:\/\/doi.org\/10.1038\/s41592-025-02807-y.","journal-title":"Nat Methods"},{"issue":"1","key":"473_CR456","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0605-2","volume":"6","author":"NM Davis","year":"2018","unstructured":"Davis NM, Proctor DM, Holmes SP, Relman DA, Callahan BJ. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome. 2018;6(1):226. https:\/\/doi.org\/10.1186\/s40168-018-0605-2.","journal-title":"Microbiome"},{"issue":"5","key":"473_CR457","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01607-23","volume":"14","author":"A Gihawi","year":"2023","unstructured":"Gihawi A, Ge Y, Lu J, Puiu D, Xu A, Cooper CS, et al. Major data analysis errors invalidate cancer microbiome findings. MBio. 2023;14(5):e0160723. https:\/\/doi.org\/10.1128\/mbio.01607-23.","journal-title":"MBio"},{"issue":"7","key":"473_CR458","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.tim.2023.01.011","volume":"31","author":"Q Wang","year":"2023","unstructured":"Wang Q, Liu Z, Ma A, Li Z, Liu B, Ma Q. Computational methods and challenges in analyzing intratumoral microbiome data. Trends Microbiol. 2023;31(7):707\u201322. https:\/\/doi.org\/10.1016\/j.tim.2023.01.011.","journal-title":"Trends Microbiol"},{"issue":"6","key":"473_CR459","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.gpb.2020.11.001","volume":"18","author":"G Yao","year":"2020","unstructured":"Yao G, Zhang W, Yang M, Yang H, Wang J, Zhang H, et al. MicroPhenoDB associates metagenomic data with pathogenic microbes, microbial core genes, and human disease phenotypes. Genomics Proteomics Bioinformatics. 2020;18(6):760\u201372. https:\/\/doi.org\/10.1016\/j.gpb.2020.11.001.","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"10","key":"473_CR460","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.ccell.2022.09.009","volume":"40","author":"B Ghaddar","year":"2022","unstructured":"Ghaddar B, Biswas A, Harris C, Omary MB, Carpizo DR, Blaser MJ, et al. Tumor microbiome links cellular programs and immunity in pancreatic cancer. Cancer Cell. 2022;40(10):1240-53.e5. https:\/\/doi.org\/10.1016\/j.ccell.2022.09.009.","journal-title":"Cancer Cell"},{"issue":"5","key":"473_CR461","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.molmed.2023.02.002","volume":"29","author":"T Ojala","year":"2023","unstructured":"Ojala T, Kankuri E, Kankainen M. Understanding human health through metatranscriptomics. Trends Mol Med. 2023;29(5):376\u201389. https:\/\/doi.org\/10.1016\/j.molmed.2023.02.002.","journal-title":"Trends Mol Med"},{"issue":"7937","key":"473_CR462","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Ni\u00f1o","year":"2022","unstructured":"Galeano Ni\u00f1o JL, Wu H, LaCourse KD, Kempchinsky AG, Baryiames A, Barber B, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 2022;611(7937):810\u20137. https:\/\/doi.org\/10.1038\/s41586-022-05435-0.","journal-title":"Nature"},{"issue":"4","key":"473_CR463","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00553-x","volume":"23","author":"S Bullman","year":"2023","unstructured":"Bullman S. INVADEseq to study the intratumoural microbiota at host single-cell resolution. Nat Rev Cancer. 2023;23(4):189. https:\/\/doi.org\/10.1038\/s41568-023-00553-x.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"473_CR464","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tim.2018.11.003","volume":"27","author":"R Eisenhofer","year":"2019","unstructured":"Eisenhofer R, Minich JJ, Marotz C, Cooper A, Knight R, Weyrich LS. Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol. 2019;27(2):105\u201317. https:\/\/doi.org\/10.1016\/j.tim.2018.11.003.","journal-title":"Trends Microbiol"},{"key":"473_CR465","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-014-0087-z","volume":"12","author":"SJ Salter","year":"2014","unstructured":"Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 2014;12:87. https:\/\/doi.org\/10.1186\/s12915-014-0087-z.","journal-title":"BMC Biol"},{"issue":"1","key":"473_CR466","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/infdis\/jiae378","volume":"233","author":"GI Austin","year":"2026","unstructured":"Austin GI, Korem T. Planning and analyzing a low-biomass microbiome study: A data analysis perspective. J Infect Dis. 2026;233(1):76\u201386. https:\/\/doi.org\/10.1093\/infdis\/jiae378.","journal-title":"J Infect Dis"},{"issue":"1","key":"473_CR467","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34409-z","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Elworth RAL, Jochum MD, Aagaard KM, Treangen TJ. De novo identification of microbial contaminants in low microbial biomass microbiomes with Squeegee. Nat Commun. 2022;13(1):6799. https:\/\/doi.org\/10.1038\/s41467-022-34409-z.","journal-title":"Nat Commun"},{"issue":"2","key":"473_CR468","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.cell.2019.12.025","volume":"180","author":"J Walter","year":"2020","unstructured":"Walter J, Armet AM, Finlay BB, Shanahan F. Establishing or exaggerating causality for the gut microbiome: lessons from human microbiota-associated rodents. Cell. 2020;180(2):221\u201332. https:\/\/doi.org\/10.1016\/j.cell.2019.12.025.","journal-title":"Cell"},{"issue":"4","key":"473_CR469","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1556\/1886.2016.00036","volume":"6","author":"U Fiebiger","year":"2016","unstructured":"Fiebiger U, Bereswill S, Heimesaat MM. Dissecting the interplay between intestinal microbiota and host immunity in health and disease: lessons learned from germfree and gnotobiotic animal models. Eur J Microbiol Immunol (Bp). 2016;6(4):253\u201371. https:\/\/doi.org\/10.1556\/1886.2016.00036.","journal-title":"Eur J Microbiol Immunol (Bp)"},{"issue":"6371","key":"473_CR470","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91\u20137. https:\/\/doi.org\/10.1126\/science.aan3706.","journal-title":"Science"},{"issue":"3","key":"473_CR471","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","volume":"20","author":"J Chuprin","year":"2023","unstructured":"Chuprin J, Buettner H, Seedhom MO, Greiner DL, Keck JG, Ishikawa F, et al. Humanized mouse models for immuno-oncology research. Nat Rev Clin Oncol. 2023;20(3):192\u2013206. https:\/\/doi.org\/10.1038\/s41571-022-00721-2.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"473_CR472","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101624","volume":"3","author":"T Dong","year":"2022","unstructured":"Dong T, Fu A, Cai S. Protocols for genetic labeling and tracing of Staphylococcus xylosus during tumor progression. STAR Protoc. 2022;3(4):101624. https:\/\/doi.org\/10.1016\/j.xpro.2022.101624.","journal-title":"STAR Protoc"},{"key":"473_CR473","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2023.103061","volume":"85","author":"JG Zalatan","year":"2024","unstructured":"Zalatan JG, Petrini L, Geiger R. Engineering bacteria for cancer immunotherapy. Curr Opin Biotechnol. 2024;85:103061. https:\/\/doi.org\/10.1016\/j.copbio.2023.103061.","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"473_CR474","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41392-025-02335-3","volume":"11","author":"Y Yao","year":"2026","unstructured":"Yao Y, Zhu Y, Chen K, Chen J, Li Y, Li D, et al. Microbiota in cancer: current understandings and future perspectives. Signal Transduct Target Ther. 2026;11(1):39. https:\/\/doi.org\/10.1038\/s41392-025-02335-3.","journal-title":"Signal Transduct Target Ther"},{"key":"473_CR475","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2026.02.011","author":"T Duan","year":"2026","unstructured":"Duan T, Rosenbaum A, Chandra V, Tiraboschi L, Rescigno M, McAllister F, et al. Toward a consensus on the tumor microbiota: Evidence, standards, and interpretation. Cancer Cell. 2026. https:\/\/doi.org\/10.1016\/j.ccell.2026.02.011.","journal-title":"Cancer Cell"},{"key":"473_CR476","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02566-6","author":"D Yan","year":"2026","unstructured":"Yan D, Yu Y, Liang C, Cui Z, Shi L, Li G, et al. Intratumoral microbiome: the double-edged sword in remodeling cancer immunotherapy. Mol Cancer. 2026. https:\/\/doi.org\/10.1186\/s12943-025-02566-6.","journal-title":"Mol Cancer"},{"issue":"42","key":"473_CR477","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202507820","volume":"12","author":"J Chen","year":"2025","unstructured":"Chen J, Chen J, Chen Y, Yuan W, Zhang J, Wang G, et al. Engineering Bacteria as Living Therapeutics in Cancer Therapy. Adv Sci (Weinh). 2025;12(42):e07820. https:\/\/doi.org\/10.1002\/advs.202507820.","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"473_CR478","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","volume":"40","author":"T Harimoto","year":"2022","unstructured":"Harimoto T, Hahn J, Chen YY, Im J, Zhang J, Hou N, et al. A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nat Biotechnol. 2022;40(8):1259\u201369. https:\/\/doi.org\/10.1038\/s41587-022-01244-y.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"473_CR479","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1038\/s41591-025-03957-4","volume":"31","author":"G Morad","year":"2025","unstructured":"Morad G, Damania AV, Melendez B, Singh BB, Veguilla FJ, Soto RA, et al. Microbial signals in primary and metastatic brain tumors. Nat Med. 2025;31(11):3675\u201388. https:\/\/doi.org\/10.1038\/s41591-025-03957-4.","journal-title":"Nat Med"},{"key":"473_CR480","doi-asserted-by":"publisher","DOI":"10.1093\/procel\/pwaf085","author":"L Niu","year":"2025","unstructured":"Niu L, Deng Z, Jin Y, Guan N, Ye H. Engineering oncolytic bacteria as precision cancer therapeutics: design principles, therapeutic strategies, and translational perspectives. Protein Cell. 2025. https:\/\/doi.org\/10.1093\/procel\/pwaf085.","journal-title":"Protein Cell"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00473-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00473-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00473-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T08:45:00Z","timestamp":1781253900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00473-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":480,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["473"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00473-w","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}